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Abstract
Fields, Jordan Alexander. Ph.D. The University of Memphis. August 2014. Exercise,
PTSD Symptoms, and Weight-Loss in Veterans Enrolled in a National WeightManagement Program. Major Professor: Meghan E. McDevitt-Murphy, Ph.D.
Evidence suggests that posttraumatic stress disorder (PTSD) may function as a
risk factor for obesity, which is linked to a number of deleterious physical health
comorbidities. Individuals with PTSD also tend to decrease their participation in exercise,
which further increases risk for adverse health outcomes. However, studies suggest that
exercise may be a promising intervention for PTSD and exercise is often included as an
important part of weight loss treatment. Military veterans are a population at high risk for
PTSD and obesity and Veterans Affairs Medical Centers (VAMC) nationwide have
instituted a weight management program (MOVE!) to address the issue of obesity in
veterans. This project included two studies, the aims of which were: to evaluate the
effectiveness of the MOVE weight management program in veterans with PTSD;
changes in PTSD symptoms upon completion of a weight management program, and to
assess differences in exercise behavior, motivation, and attitudes between veterans with
and without PTSD. The first study used archival data from the Memphis VAMC
computerized patient records system to examine differences between PTSD and nonPTSD patients on MOVE program outcomes (body weight, blood pressure, respiratory
rate, glucose, and cholesterol). The second study used prospective data from veterans
currently participating in the MOVE program to evaluate exercise behavior, motivation,
and attitudes in PTSD and non-PTSD patients.
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Exercise, PTSD Symptoms, and Weight-loss in Veterans Enrolled in a National Weight
Management Program
Introduction
Posttraumatic stress disorder (PTSD) is one of the most striking potential
consequences of psychological trauma. PTSD can develop as a result of witnessing or
experiencing a traumatic experience and is marked by a constellation of symptoms
including re-experiencing the traumatic event, avoiding situations that may be related to
the trauma and/or emotional numbing, and extreme levels of hyperarousal. Recent
estimates for lifetime prevalence of PTSD have been around 7% in nationally
representative samples of U.S. adults (Kessler et al., 2005) and military veterans have
shown to be at even higher risk for developing PTSD, with some studies showing
prevalence greater than 20% (Pietrzak, Johnson, Goldstein, Malley, & Southwick, 2009).
Particularly concerning, given these high rates, is the growing body of literature
documenting the relationship between PTSD and physical health comorbidities. It has
been proposed that PTSD is linked to adverse physical health outcomes due to the
adoption of health habits that promote poorer health, such as substance abuse (Perkonigg,
Owashi, Stein, Kirschbaum, & Wittchen, 2009), smoking (Chwastiak, Rosenheck, &
Kazis, 2011) and a combination of overeating and reduced physical activity that leads to
obesity (Chwastiak et al., 2011; Hudson, Hiripi, Pope Jr., & Kessler, 2007). Obesity is of
particular concern, given the fact that it is associated with severe health conditions like
heart disease, hypertension, diabetes, stroke, and dyslipidemia (Almond, Kahwati,
Kinsinger, & Porterfield, 2008; Bray, 2004; Nelson, 2006).
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The prevalence of obesity has reached an all-time high in the US population, with
approximately 1 in 3 adults being classified as obese, defined as a body mass index
(BMI) greater than 30 (Allison, Zanolli, & Narayan, 1999). Due to the health
implications of obesity, it is important to develop efficacious programs for weight
management. Veterans Affairs Medical Centers (VAMCs) have introduced a nationwide
program (MOVE Weight Management Program for Veterans) to address the problem of
obesity in veterans. Given the high prevalence of PTSD in VA hospitals and the apparent
connection between PTSD and obesity, it is important to investigate whether veterans
with PTSD respond well to this program.
PTSD and Medical Comorbidity
A number of studies have evaluated the relationship between PTSD and physical
health comorbidities in the general population and found significant relationships.
Lauterbach and colleagues (2005) analyzed data from 5,877 civilians assessed in the
National Comorbidity Survey (NCS) and found that those with PTSD were twice as
likely as those without PTSD to report at least one of the 14 medical conditions assessed
by the NCS. Even after controlling for sex, health perceptions, stress, health-related
behaviors, insurance coverage, total trauma exposure, total number of psychiatric
diagnoses, and neuroticism, the PTSD group was more likely to report the presence of a
medical condition. Gaizo and colleagues (2011) conducted a study using data from the
National Comorbidity Study Replication (NCS-R) and examined the relationship between
PTSD, trauma exposure, physical health, and substance abuse in a nationally
representative sample of 4,954 adults and found that PTSD mediated the relationship
between the number of traumatic events and physical health comorbidities
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(gastrointestinal, musculoskeletal, and cardiovascular). Sledjeski and colleagues (2008)
used NCS-R data to examine the number of lifetime traumas in relation to PTSD
symptoms and physical health in a sample of 5,692 adults with clinically significant
psychopathology. Participants were divided into 3 groups: those meeting full criteria for
PTSD, those with trauma exposure but no PTSD, and those with no trauma. Results of
the study showed that PTSD diagnosis was associated with the highest likelihood of
chronic pain and ulcers followed by the trauma-exposed and no-trauma groups
respectively. The PTSD and trauma-exposed group evidenced similar rates of seasonal
allergies, diabetes, and cancer, while the no trauma group showed significantly lower
rates of these conditions. Interestingly, results from this study suggested that trauma
exposure, and not PTSD per se, might be the most relevant factor in determining medical
morbidity. After controlling for number of traumas, PTSD was only related to one
chronic pain condition and the lifetime number of traumas was a significant predictor of
the majority of chronic medical conditions.
Spitzer and colleagues (2009) examined the relationships between trauma and
PTSD, and a host of medical conditions, including cardiovascular, endocrine, pulmonary,
and other chronic diseases in a general population sample of 3,171 adults. After adjusting
for demographics, smoking status, BMI, blood pressure, depression, and alcohol use, the
PTSD group had close to 3 times higher risk of developing bronchitis, asthma, liver
disease, and peripheral arterial disease compared with non-PTSD participants. Pietrzak
and colleagues (2012) studied the relationship between PTSD and physical health
comorbidities in a sample of 9,463 older adults from the National Epidemiologic Survey
on Alcohol and Related Conditions (NESARC) and found that older adults who had

	
  

10	
  

	
  
lifetime PTSD diagnoses were more likely than trauma-exposed individuals to report
being diagnosed with hypertension, angina pectoris, tachycardia, stomach ulcer, gastritis,
and arthritis. Dirkzwager and colleagues (2007) examined the relationships between
PTSD and self-reported and physician reported physical health in 896 adults and found
that after adjusting for demographics, smoking behavior, and pre-disaster physical health,
PTSD was associated with vascular, musculoskeletal, and dermatological problems.
Prospective analysis showed that survivors with PTSD were almost twice as likely as
survivors without PTSD to be diagnosed with new vascular problems following the initial
assessment.
Men and women experience traumatic events at similar rates (Spitzer et al.,
2009), but despite this, women are twice as likely to develop PTSD. A handful of studies
have looked at PTSD and comorbid medical conditions in female samples. Gill and
colleagues (2009) examined the relationship between PTSD and comorbid medical
conditions in a sample of 250 women who were seeking healthcare at an urban clinic.
After controlling for demographics and depression, women diagnosed with PTSD were
more likely to report current and past medical conditions than women without PTSD.
Seng and colleagues (2006) examined categories of disease, chronic conditions
associated with sexual assault, and reproductive health conditions in a large sample (N =
17,081) of women with and without PTSD who were receiving Medicaid. Among
postmenopausal women, those with PTSD had higher odds of digestive, genitourinary,
and musculoskeletal conditions than those without PTSD. Reproductive age women with
PTSD had higher odds of all chronic health conditions and gynecological health problems
than reproductive age women without PTSD. Ciechanowski and colleagues (2004)
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studied the relationship between PTSD and adult health status in a large sample of female
HMO enrollees (N = 1,225) and found that women with moderate to high PTSD
symptom severity reported having a greater degree of functional impairment, a greater
number of common physical symptoms, and a greater number of physician diagnosed
ICD-9 codes than the non-PTSD group. The PTSD group also reported significantly more
pain conditions than the non-PTSD group.
The studies reviewed above show that PTSD has been linked to a wide array of
comorbid physical health conditions, ranging from cardiovascular to endocrine diseases.
The results of these studies suggest that PTSD may mediate the relationship between
trauma exposure and physical health comorbidity. Interestingly, PTSD also proved to be
predictive of physical health problems above and beyond factors like smoking behavior
and physical inactivity, which have been noted to have functional relationships with
many of the reported physical comorbidities.
Studies in Veteran Samples
The vast majority of the studies looking at the relationship between PTSD and
physical health comorbidity have been conducted in samples of military veterans. Due to
the nature of their jobs, military personnel are at particularly high risk for developing
PTSD (Gates et al., 2012) and subsequently physical health comorbidities. Veterans
diagnosed with PTSD have shown significantly higher odds of developing several
distinct physical comorbidities (chronic rashes, eczema, musculoskeletal conditions,
asthma, hypertension, nervous system, digestive system, and ill-defined conditions or
diseases) compared to non-PTSD veterans (Andersen, Wade, Possemato, & Ouimette,
2010; O’Toole & Catts, 2008).
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The majority of these studies linking PTSD to physical health conditions have
been conducted using self-reports of physical health. Tate and colleagues (2007)
examined PTSD, and physical health in a sample of 121 male veterans with substanceuse disorders (SUD), with and without trauma histories. Both the SUD-PTSD and SUDtrauma groups had higher rates of chronic health conditions compared to the SUD-only
groups, but did not differ from each other. Maia and colleagues (2011) examined the
relationship between combat exposure, PTSD, and physical health in a sample of 250
Portuguese colonial war veterans. Controlling for histories of childhood abuse and
neglect, war exposure, psychological distress, and PTSD were significant predictors of
reported illnesses. Mediation analyses showed that PTSD fully mediated the relationship
between war exposure and reported illnesses, explaining much of the relationship
between war exposure and physical illness. Dennis and colleagues (2009) examined
lifetime trauma rates, PTSD, and health conditions in a sample of 148 veteran and nonveteran women with self-reported diagnoses of PTSD, major depressive disorder (MDD),
or neither diagnosis, and found PTSD and MDD to be associated with past year health
conditions. Hovens and colleagues (1998) compared self-reports of physical health in 147
male Dutch World War II Resistance veterans with and without PTSD and 252
participants from a general population survey and found that veterans were significantly
more likely to report at least one health condition over the past year than those in the
general population. Veterans with PTSD were not more likely to report more diseases in
the past year than non-PTSD veterans, but veterans with PTSD reported a significantly
higher number of lifetime diseases than veterans without PTSD. Barrett and colleagues
(2002) looked at the relationship between PTSD and physical health in a large

	
  

13	
  

	
  
population-based study of 3,682 Gulf War veterans and found that veterans with PTSD
reported a significantly higher number of medical conditions than non-PTSD veterans.
Several studies have examined the relationship between PTSD and self-reported
physical health in samples of Vietnam War veterans. For example, Litz and colleagues
(1992) studied the relationship between PTSD and physical health in a sample of 37
Vietnam combat veterans and found that veterans diagnosed with PTSD reported more
physical health complaints (e.g., arrhythmia, shortness of breath, racing heart, etc.), but
did not differ from non-PTSD veterans on the number of self-reported physiciandiagnosed medical disorders (e.g., hypertension, diabetes, respiratory disease, etc.).
Beckham and colleagues (2003) were interested in the potential mediating role heart
functioning plays in the relationship between PTSD and physical health outcomes. They
examined 12-14 hr blood pressure/heart rate monitoring and self-reported physical health
in a sample of 117 male Vietnam War veterans with and without PTSD. Controlling for
blood pressure and heart functioning PTSD diagnosis was associated with reporting a
greater number of health conditions. Several ambulatory readings were taken, and only
the percentage of heart rate readings above baseline, a physiological measure of
hyperarousal indicated by the proportion of readings above initial mean heart rate
readings, was associated with both PTSD and physical health outcomes. Mediation
analysis indicated that the percentage of heart rate readings above baseline did not
mediate the relationship between PTSD and physical health. Taft and colleagues (1999)
analyzed the data of 1,632 participants from the National Vietnam Veterans
Readjustment Survey, modeling the roles of combat exposure, PTSD, and personal
resource attributes (hardiness and social support) in relation to physical and functional
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health. Path analysis showed that both combat exposure and PTSD were significantly
related to physical health conditions, but a diagnosis of PTSD had a three-times stronger
relationship with physical health conditions than combat exposure in men and was more
than twice as predictive than combat exposure alone for women, suggesting that the
effects of variables like combat exposure on physical health are secondary to the effect of
PTSD (Taft, Stern, King, & King, 1999). Wolfe and colleagues (1994) examined the
associations between war zone exposure, PTSD, and physical health comorbidity in a
sample of 109 non-treatment seeking female Vietnam veterans. Both PTSD and war zone
exposure were associated with physical health conditions, but when the effects of each
variable were controlled, the association between PTSD and physical health remained
significant while the effect of war zone exposure was substantially diminished. Boscarino
and colleagues (2004) conducted a study of 2,490 Vietnam veterans focused on the
prevalence of autoimmune diseases in veterans with chronic PTSD. Vietnam veterans
with PTSD were more likely than non-PTSD veterans to report diagnoses of psoriasis,
glomerulonephritis, and any type of autoimmune disease. In addition to these findings
Boscarino and colleagues (2004) conducted laboratory tests on participants and found
that participants with chronic PTSD had increased risk of rheumatoid arthritis, psoriasis,
insulin-dependent diabetes, and thyroid disease, suggesting that PTSD has a substantial
physiological impact beyond the cognitive level.
A few studies that examined the relationship between PTSD and physical health
have used physician diagnoses. Buckley and colleagues (2004) evaluated physiciandiagnosed medical problems in 826 veterans, 83.7% of whom had a primary diagnosis of
PTSD, referred to a Veterans Affairs Medical Center (VAMC) PTSD clinic for
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assessment and compared them to general population estimates for diseases. Results
indicated that when compared to men of comparable age without PTSD, the sample of
veterans with PTSD had higher rates of asthma, arthritis, tuberculosis, diabetes, stroke,
cancer, myocardial infarction and cirrhosis of the liver. Calhoun and colleagues (2009)
used a mixed veteran/non-veteran sample of 198 women to examine the contribution of
depression to physical health comorbidity in women with PTSD. Women with PTSD had
significantly more physician-diagnosed illnesses than women without any diagnosis, but
did not differ from women with both PTSD and MDD or women solely diagnosed with
MDD. Possemato and colleagues (2010) examined the relationship of PTSD, depression,
and substance use disorders to medical comorbidity in a large sample (N = 4,463) of
Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans, data for
whom were collected over a 6-year period. Controlling for covariates, PTSD was
significantly associated with the number of major categories of ICD-9-CM medical
conditions. Additionally, veterans with PTSD accrued diseases at a significantly higher
rate than veterans without PTSD. Recently, there has been an increased interest in the
unique associations between combat exposure and physical health. Schnurr and
colleagues (2000) investigated the relationship between PTSD and physician diagnosed
medical conditions in 605 older combat veterans from World War II and the Korean War.
After controlling for age and health-risk behaviors (smoking, alcohol use, BMI), PTSD
was associated with a 27% increased risk for arterial disorders, a 23% increased risk for
lower gastrointestinal disorders, an 18% increased risk for dermatological disorders, and
a 9% increased risk for musculoskeletal disorders. Schnurr and colleagues (2000) tested
the role of PTSD as a mediator in the relationship between combat exposure and physical
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health outcomes (cardiovascular, malignant cancer, endocrine, upper gastrointestinal,
lower gastrointestinal, genitourinary, dermatologic, and musculoskeletal) in this sample
and found that, with the exception of pulmonary disorders, when PTSD was entered into
hierarchical survival analyses for each disorder category, the relationship between
combat exposure and health outcomes were no longer significant. Nazarian and
colleagues (2012) conducted a recent study evaluating the effects of PTSD and SUDs on
medical comorbidity in a large sample (N = 73,720) of returning male and female
OEF/OIF veterans and found that both male and female veterans with PTSD had higher
odds of developing diseases from 9 out of 11 categories of medical categories compared
to those without PTSD. Male and female veterans with SUD had significantly increased
odds of developing conditions from 3 and 2 disease categories respectively.
The results of these studies provide evidence for the association between PTSD
and physical health comorbidities in general population and veteran samples. A handful
of studies have shown that this relationship may be above and beyond other factors that
have been previously linked to poor physical health outcomes, like trauma and combat
exposure. PTSD may exert its negative effect on physiological health through a number
of pathways including, disruptions in the hypothalamic-pituitary-adrenal axis,
sympathetic-adrenal-medullary axis, and the inflammatory response system.
Additionally, PTSD may exert its negative effects on physical health through the
development of negative health behaviors. Individuals diagnosed with PTSD are at risk
for the development of substance use disorders and decreased levels of physical activity,
which are associated with poorer health. The physiological and behavioral disruptions
associated with PTSD may put individuals with the disorder at risk for a number of
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medical conditions. Further, the physiological changes associated with PTSD may
function as an added barrier for benefiting from programs focused on reducing weight,
like the MOVE! program.
PTSD and Cardiovascular Disease
As discussed previously, PTSD has been associated with several comorbid
physical health conditions. Perhaps most concerning is the relationship between PTSD
and cardiovascular diseases (CVDs), which has been documented as the leading cause of
death worldwide. Three epidemiologic samples have examined the relationship between
PTSD and CVD and found strong associations. Sareen and colleagues (2007) analyzed
the data from 36,984 Canadians over the age of 15 in the Canadian Community Health
Survey Cycle and found that, after adjusting for demographic factors, a diagnosis of
PTSD was associated with increased odds of CVDs. Glaesmer and colleagues (2011)
examined the relationship between trauma, PTSD, and physical comorbidities in a
representative sample of 1,456 older German adults and found that participants with a
current PTSD diagnosis were more likely to report CVDs (including coronary artery
disease, congestive heart failure, and peripheral vascular disease) than patients without
PTSD. Kubzansky and colleagues (2007) conducted a prospective study of PTSD and
coronary heart disease in 2,280 veterans from the Normative Aging Study and found that
each standard deviation in PTSD symptom increase was associated an 18% increased risk
for coronary heart diseases even after controlling for other risk factors (age, smoking
status, systolic and diastolic blood pressure, serum total cholesterol level, etc.). Sawchuk
and colleagues (2005) looked at the relationships among PTSD, depression, and CVD in
a sample of 1,414 Northern Plains Native Americans and found that participants with
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PTSD were more likely to report a diagnosis (by a doctor, medicine man, or other healthcare professional) of CVD than those without PTSD. Additionally, regression analysis
showed that after controlling for demographics and depression, PTSD continued to hold a
strong relationship with CVD.
Two studies examined the relationship between PTSD and CVD in all female
samples and found significant relationships between the two conditions. Kubzansky and
colleagues (2009) examined this relationship in a prospective study of 1,059 women from
the Epidemiological Catchment Area study and found that women who reported 5 or
more symptoms of PTSD had more than 3 times the odds of developing heart disease
compared to women with no symptoms. Dobie and colleagues (2004) examined the
relationship between screens for PTSD and self-reported physical health problems in a
sample of 1,206 female veterans and found that a positive screen for PTSD was
associated with increased odds (1.76 [.86, 3.60]) of myocardial infarction and coronary
heart disease.
A handful of studies looked at the relationship between PTSD and
subclinical/cardiovascular disease risk factors. One cluster of risk factors has been
labeled “Metabolic syndrome,” defined as the simultaneous presence of at least three of
the following cardiovascular disease risk factors: obesity, high levels of triglycerides, low
HDL cholesterol, high blood pressure, and high fasting glucose level. Metabolic
syndrome represents a unique clustering of risk-factors for CVD, which has been
associated with type 2 diabetes mellitus and mortality (Citrome, 2005). Violanti and
colleagues (2006b) examined the relationship between PTSD and metabolic syndrome in
116 police officers and found that there was an increased prevalence of metabolic
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syndrome in officers with severe PTSD when compared to officers with low levels of
PTSD symptoms. Weiss and colleagues (2011) evaluated the relationship between PTSD
and metabolic syndrome in 245 adults from low socioeconomic backgrounds and found
that participants diagnosed with current PTSD were more likely to exhibit metabolic
syndrome than participants without current PTSD. Interestingly, a lifetime diagnosis of
PTSD was not associated with the presence of metabolic syndrome. Falger and
colleagues (1992) examined the relationship between PTSD and CVD in 147 Dutch
World War II veterans and found that veterans with PTSD were more likely to report a
prior myocardial infarction and angina pectoris than non-PTSD veterans. Violanti and
colleagues (2006a) examined associations between PTSD symptoms and subclinical
cardiovascular disease in 100 police officers and found that officers with severe PTSD
symptoms showed more severe CVD biomarkers than officers with mild PTSD
symptoms. Cohen and colleagues (2009) examined associations between CVD risk
factors and mental health diagnoses in 303,223 OEF veterans and found that veterans
with PTSD were at risk for all cardiovascular disease risk factors (tobacco use,
hypertension, dyslipidemia, obesity, and diabetes) and had the highest odds of exhibiting
these risk factors.
A few studies have examined the relationship between PTSD and CVD in veteran
samples. Schnurr and colleagues (2000) examined associations between PTSD and
physician-diagnosed medical disorders in older male veterans and found that 10-point
increases (SD = 11.00) on the Mississippi Scale for Combat-Related PTSD were
associated with 27% increased risk for arterial disorders. Boscarino and colleagues
(2006) evaluated the relationship between PTSD and mortality among 15,288 veterans
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and found that only veterans with PTSD had increased odds of death due to
cardiovascular disease. In a prospective study of heart disease-related mortality among
1,972 Vietnam veterans, Boscarino and colleagues (2008) found that a diagnosis of PTSD
at baseline was predictive of doubled the risk of death from early-onset heart disease at
follow-up.
Studies have investigated the relationship between PTSD and cardiovascular
disease risk factors, like metabolic syndrome, and have found significant relationships.
These studies suggest that PTSD may be related to cardiovascular disease through a
constellation of physiological risk-factors. PTSD has been linked to cardiovascular
disease in several populations and it appears that PTSD may function as a risk factor for
cardiovascular disease-related morbidity and mortality. In light of the link between PTSD
and risk for cardiovascular disease, it is probable that PTSD induces sustained
cardiovascular abnormalities, which may be evidenced in basic vital signs like heart rate.
PTSD and Overweight/Obesity
Of the physical health outcomes associated with PTSD, the link between PTSD
and obesity is gaining increased attention. Obesity, defined as a BMI greater than 30, is a
considerable public health concern due to its relationship with hypertension, type 2
diabetes, stroke, osteoarthritis, coronary heart disease, and a number of other diseases and
complications. Several studies point to a link between PTSD and risk for obesity, which
has implications for the pathogenesis of obesity-related diseases.
Four epidemiologic studies have examined the relationship between PTSD and
obesity and found links between the two disorders. Perkonigg and colleagues (2009)
conducted a prospective, longitudinal study with a representative sample of 3,021
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German adolescents and young adults and found PTSD to be associated with increased
risk of having a BMI over 30. Prospective analyses showed that, after controlling for
other possible predictors (e.g., age, social class, other mental disorders), antecedent
lifetime PTSD and subthreshold PTSD were significant predictors of future PTSD among
women, but not men. Scott and colleagues (2008) examined the relationship between
mental disorders and obesity in a general population study of 12,992 New Zealand adults
and found PTSD to have the strongest relationship to obesity of any mood or anxiety
disorder. Pagoto and colleagues (2012) evaluated the association between PTSD and
obesity in a sample of 20,013 adults from the Collaborative Psychiatric Epidemiologic
Survey (CPES). PTSD was associated with increased odds of being obese (1.51 [1.18,
1.95]) after controlling for covariates (e.g., smoking status, sex, age, depression, alcohol
abuse/dependence). The role of binge eating disorder (BED) was examined in this
relationship and the results showed that BED did not mediate the relationship between
PTSD and obesity. Finally, Chwastiak and colleagues (2011) examined relationship
between psychiatric illness and obesity in a national sample of 501,161 veterans from the
Large Health Survey of Veteran Enrollees and found that PTSD was associated with
increased risk of obesity.
One study examined the relationship between PTSD and obesity in a sample of
women with childhood traumas and found that PTSD mediated the relationship between
childhood trauma and obesity. Dedert and colleagues (2010) modeled the relationship
between childhood traumas (physical and sexual abuse) and obesity, with PTSD and
MDD as mediating variables in a sample of 148 women. In this sample both childhood
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sexual and physical abuse had simple indirect effects on BMI through PTSD, but not
depression.
A recent 16-year prospective study examined the relationship between PTSD and
weight status in 54,224 women enrolled in the Nurses’ Health Study II. Kubzansky and
colleagues (2014) found that women who screened positive for at least four symptoms of
PTSD prior to entry in the study had a greater increase in BMI during follow-up
compared to women with fewer symptoms. Notably, the presence of at least 4 symptoms
of PTSD at the beginning of the study was associated with increased odds (OR 1.36) of
becoming overweight/obese among women with normal BMI.
One study assessed obesity in a sample of veterans seeking treatment for PTSD
and found a mean BMI greater than 25. Buckley and colleagues (2004) looked at the
relationship between PTSD and BMI in 826 veterans referred for assessment in a VA
PTSD clinic and found that the mean BMI of the sample was 28.7, which is in the
overweight range.
Three studies compared rates of overweight and obesity in veterans diagnosed
with PTSD to national findings from U.S. epidemiologic surveys and found that rates of
overweight and obesity in veterans with PTSD greatly exceeded the national prevalence.
Specifically, Vieweg and colleagues (2006a) found a high prevalence of overweight
(38.2%) and obesity (40.1%) in 157 male veterans diagnosed with PTSD, compared to
findings from the National Health and Nutrition Examination Survey (NHANES) of U.S.
adults of 34.0% and 30.5% of overweight and obesity respectively. Vieweg and
colleagues (2006b) examined this relationship in a sample of 221 male veterans
diagnosed with PTSD and found that 82.8% of their sample was overweight or obese.
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Finally, Vieweg and colleagues (2006c) examined this relationship in a sample of 265
male veterans diagnosed with PTSD and found that rates of overweight and obesity in
their sample exceeded national findings by close to 20%.
Five studies evaluated the relationship between PTSD and obesity in samples of
veterans with and without diagnoses of PTSD. Kozaric-Kovacic and colleagues (2009)
evaluated the relationship between PTSD and obesity in a sample of Croatian veterans
with (N = 269) and without PTSD (N = 209) and healthy controls (N = 1553). Controlling
for trauma, age, smoking, alcohol consumption, physical activity, and comorbid
psychiatric disorders they did not find a difference in BMI between veterans with or
without PTSD and healthy control subjects. The authors of the study noted a limitation to
their study, which may impact their findings, is the small number of veterans with or
without PTSD compared to healthy controls. They also noted that compared to other
samples with positive findings, their sample was homogeneous, including only
Caucasians of Croatian descent. Barber and colleagues (2011) studied PTSD symptoms
and obesity in 1,553 OEF/OIF veterans who screened positive for PTSD on the Primary
Care PTSD Screen (PC-PTSD) and did not find a relationship between screening positive
for PTSD and obesity. Limitations to the study were noted including, the high prevalence
of overweight/obesity in veterans seeking healthcare at the VA compared to those who
seek private healthcare and the use of screening instruments as measures of psychological
distress. Trief and colleagues (2006) studied correlates of comorbid PTSD and diabetes in
a sample of 14,438 male VA patients diagnosed with diabetes and comorbid PTSD,
PTSD and depression, depression, or other psychiatric disorders, and found that
participants diagnosed with PTSD and comorbid depression evidenced worse outcomes
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on cholesterol levels and low-density lipoproteins than patients with depression-only and
had higher BMI than patients without either diagnosis. Vieweg and colleagues (2007)
examined the relationship between PTSD and obesity in a national sample of veterans
with (N = 1819) and without (N = 44,959) PTSD and a local sample of veterans with
PTSD (N = 519) and found that in the national sample, veterans with PTSD had higher
BMI than those without PTSD. The local sample had a mean BMI of 30, and 82% were
overweight or obese, which is notable given that the veteran population is already at risk
(75.6%) for obesity. Finally, David and colleagues (2004) compared veterans with PTSD
(without alcohol use: N = 55) and those with alcohol dependence (without combat
exposure or lifetime PTSD: N = 38) with respect to rates of obesity and found that
veterans with PTSD were more likely to be diagnosed with obesity than alcohol
dependent veterans.
PTSD has been associated with increased odds of overweight and obesity in a
number of epidemiologic samples and has been shown to mediate the relationship
between childhood traumas and obesity (Dedert et al., 2010). Veterans with PTSD have
also shown higher rates of obesity than expected from national samples. The connection
between PTSD and obesity is intriguing and PTSD may contribute to the development of
obesity through several pathways. PTSD is associated with dysfunction of the
hypothalamic-pituitary-adrenal axis, thyroid, and dysregulation of cortisol secretion,
which have been linked to weight gain. PTSD may also increase risk for obesity through
negative health behaviors. PTSD is associated with decreased levels of physical activity,
which can lead to a sedentary lifestyle and greater calorie intake than energy expended.
In addition to this, combat veterans may have a decreased ability to engage in exercise
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subsequent to physical injuries, which may result in an energy imbalance and increased
weigh. PTSD is linked to overeating, which is a risk factor for obesity. Dysregulated
eating patterns like overeating may result from high levels of impulsivity, self-medication
with food, or disruptions in the hypothalamic-pituitary-adrenal axis. PTSD may also
increase risk for obesity through high levels of alcohol use, which can create an energy
imbalance similar to overeating. Obesity represents an increased risk for a number of
adverse health consequences and is particularly important because of its link to the
pathogenesis of cardiovascular disease. The relationship between PTSD and obesity
points to the potential for physical and behavioral impediments facing individuals
seeking to lose weight
PTSD and Health Risk Behaviors
PTSD and substance use. A substantial body of literature documents the
relationship between PTSD and substance-related health-risk behavior. In particular,
PTSD has been linked to tobacco smoking and alcohol use (Buckley, Mozley, Bedard,
Dewulf, & Greif, 2004; Chwastiak et al., 2011; Del Gaizo et al., 2011; Kozaric-Kovacic
et al., 2009; Zen, Whooley, Zhao, & Cohen, 2012). Smoking has been found to cause
CVD through atherosclerosis of coronary arteries, dyslipidemia, and increased
thrombosis. Alcohol consumption exceeding 3 drinks per day has been associated with
increased blood pressure, heart rate, and coronary artery disease. The consumption of
excessive calories in the form of alcohol can also lead to obesity, and increased risk for
cardiovascular disease. Excessive alcohol use may be one reason for the link between
PTSD and CVD (Vaccarino et al., 2013).
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PTSD is associated with a number of health risk behaviors that place patients at
an increased risk for negative health outcomes, and in particular, cardiovascular disease.
Physical inactivity, smoking, and alcohol use are health-risk behaviors, which hold strong
connections to PTSD and CVD. Exercise has been indicated as an intervention for
individuals with PTSD and is an essential preventive health behavior.
PTSD and Exercise. Some evidence shows that PTSD is associated with
significantly reduced activity, and with less planned exercise behavior, relative to nonPTSD controls. Few studies have looked at changes in exercise behavior in patients
diagnosed with PTSD. Kozaric-Kovacic and colleagues (2009) looked at PTSD and
physical activity in a sample of 478 Croatian veterans and found that veterans with PTSD
were significantly less frequently engaged in physical activity than veterans without
PTSD, controlling for trauma, age, smoking, alcohol consumption, physical activity, and
comorbid psychiatric disorders. Rutter and colleagues (2011) examined the relationships
among PTSD symptoms, exercise, and health in 200 college students and found that
PTSD was associated with less physical exercise and poor health status. Mediation
analyses showed that exercise mediated the relationship between PTSD and general
physical health (negative health symptoms, functional health). Zen and colleagues (2012)
looked at associations between PTSD and health behaviors in 1,022 men and women
diagnosed with CVD and found that PTSD was associated with significantly lower rates
of physical activity compared to non-PTSD individuals. De Assis and colleagues (2008)
assessed physical activity habits in 50 adult Brazilian patients with PTSD and found that
PTSD onset was associated with significant reductions in participation in sports and
physical activities. In Lauterbach and colleagues’ (2005) evaluation of the relationship
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between PTSD and health problems in 5,877 respondents, participants diagnosed with
PTSD were less likely to exercise than those without the disorder. Chwastiak and
colleagues (2011) looked at PTSD and physical inactivity in a national sample of 501,161
veterans and found that veterans diagnosed with PTSD had significantly decreased odds
of engaging in regular exercise.
Cross-sectional studies suggest that PTSD is related to decreased levels of
physical activity. These lower levels of physical activity are important because physical
activity is related to better physical and mental health. Also, an inactive or sedentary
lifestyle is a risk factor for the development of obesity and cardiovascular disease.
Exercise interventions for PTSD. There is a substantial body of literature
establishing the efficacy of exercise interventions for psychological disorders
(Stathopoulo, Bowers, Berry, Smits, & Otto, 2006). Emerging evidence suggests that
exercise interventions may be effective in treating symptoms related to PTSD.
Manger and Motta (2005) conducted a study of an aerobic exercise (walking or
jogging) intervention in 26 community dwelling adults. Six participants met full criteria
for PTSD as measured by the CAPS. Following the intervention, two participants met
criteria for PTSD, and 4 met criteria at 1-month follow-up. Paired sample t-tests showed
significant reductions in CAPS scores from pre-intervention baseline scores (M = 56.67;
SD = 22.51) to post-intervention (M = 36.67; SD = 16.52) and follow-up scores (M =
40.56; SD = 10.52). Participants also evidenced significant reductions in trait, but not
state, anxiety and depressive symptoms following the intervention.
Newman and Motta (2007) conducted a study of an aerobic exercise (e.g., dance,
Tae Bo, jog) program in a sample of 15 adolescent females from a residential treatment
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facility for children with significant problems at home or school. Participants’ PTSD
symptoms were stable across the 2-week and 4-week pre-intervention periods with no
differences between the groups at the end of these periods. Significant reductions in
PTSD from baseline to post-intervention were found as measured by the CPTSDI and
PTSD-RI. Reductions in anxiety and depressive symptoms were also found.
Diaz and Motta (2008) conducted a study of an aerobic exercise (walking)
treatment in a sample of 12 adolescent females in a residential treatment facility. Ten
participants evidenced significant decreases in PTSD symptoms post-intervention. Six
participants showed stable levels of anxiety during the pre-intervention period, three of
whom showed significant decreases in symptoms following intervention, while 2 showed
no changes in symptoms and 1 participant showed an increase in anxiety. Eight
participants showed stable levels of depression over the baseline period with only 2
participants experiencing significant decreases in depression post intervention.
Three studies evaluated exercise interventions for individuals diagnosed with
PTSD and found exercise to decrease PTSD symptoms in adolescent female and adult
samples. Two of the studies showed significant decreases in anxiety and depression
symptoms (Manger & Motta, 2005; Newman & Motta, 2007), while one study did not
show such decreases (Diaz & Motta, 2008). However, it was noted that participants in the
latter study exhibited low baseline levels of anxious and depressive symptoms. From
these studies, it appears that there is initial evidence for the use of exercise interventions
for the treatment of PTSD. The role of exercise as a potential mode of treatment for
PTSD is particularly important as it may function as a tool for addressing the emotional
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distress associated with PTSD, and exercise functions as a crucial component of weightloss interventions.
Weight Loss Interventions
The prevalence of obesity is at an all-time high in the U.S. and this is particularly
problematic because of the comorbidity of obesity with a number of diseases
(dyslipidemia, diabetes, cardiovascular disease, osteoarthritis). Overweight and obese
people can substantially reduce their risk for these severe health consequences by losing
weight. Consistent evidence shows that weight loss produced by lifestyle modifications
lowers blood pressure, total cholesterol, triglycerides, and elevated blood glucose levels
(Hassapidou et al., 2011). Most successful weight loss programs consist of a combination
of dietary therapy (calorie restriction), behavioral modification, and physical activity to
achieve weight loss resulting in weight losses of 6 to 8 pounds over the course of 6
months to 1 year (Jain, 2004).
Dietary therapy is a core component of weight loss interventions and exercise
plays an important role in the processes of weight loss and weight maintenance due to the
positive metabolic benefits of exercise (Jain, 2004; Weinheimer, Sands, & Campbell,
2010; Sciamanna et al., 2011). It is also important to note that exercise is associated with
increased cardiorespiratory fitness, decreases in abdominal fat and decreased risk for
CVD in overweight and obese individuals (Anderssen et al., 1995; Stefanick et al., 1998;
Weinheimer, Sands, & Campbell, 2010).
The MOVE! Weight Management program. Approximately 70% of veterans
are overweight or obese, placing them at risk for the negative sequelae of excess weight
(Littman, Boyko, McDonell, & Fihn, 2011). In response to the high rates of overweight

	
  

30	
  

	
  
and obesity in veterans seeking services in the VA system, VAMCs nationwide have
instituted a weight management program to address the needs of a growing overweight
and obese population. The VA system has developed a program, which includes periodic
screening for overweight and inactivity (identifying patients in need of weight reduction
focused intervention), 12 weeks of group counseling regarding diet, exercise, and
behavior modification, and medical record documentation of weight status, physical
activity, and physical health comorbidities related to overweight and obesity. Veterans’
heights and weights are recorded at primary care visits and physicians are alerted to refer
the veteran to the MOVE! program if their calculated BMI exceeds 25. If veterans are
physically capable of engaging in the program and choose to enter the MOVE! program,
they begin group sessions consisting of motivational interventions, dietary instruction,
and physical activity counseling. The MOVE! program was designed to so that even
disabled veterans can participate and work towards weight loss (MOVE! Weight
Management Program Clinical Reference Manual, 2005).
Only a few studies have evaluated outcomes related to the MOVE! weight
management program. Dahn and colleagues (2011) assessed the trajectories of weight
change prior and subsequent to participation in the MOVE! program in 1000 veterans and
found that prior to treatment veterans gained approximately 4 pounds per year and after
enrollment in the program, veterans lost on average 3 pounds per year. Taft and
colleagues (2011) evaluated the effectiveness of the MOVE! program in a sample of 237
veterans. BMI did not differ between African American patients and non-African
American patients at baseline or at 12-month follow-up and patients lost on average 1.96
pounds, but African American patients demonstrated significantly less weight loss than
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non-African Americans. Littman and colleagues (2012) evaluated the MOVE! program in
3,192 participants and found that MOVE! program participants lost significantly more
weight than eligible non-participants at 6-month and 12-month follow-up.
The MOVE! program has shown to be effective in initial evaluation studies with
veterans altering trends from pre-treatment weight gain to post-treatment weight loss and
participants showing greater weight loss than eligible non-participants. The MOVE!
program addresses an important concern for veteran health. However, the effectiveness of
this program has not been evaluated for veterans diagnosed with PTSD, a large and
important subgroup of veterans treated in VA medical centers. This is important because
veterans with PTSD are at increased risk for obesity, CVD, and negative health behaviors
associated obesity and CVD. Additionally, PTSD is associated with alterations in key
physiological systems that play roles in weight gain, which may effect weight loss
efforts. This is of particular relevance given the high base rate of PTSD in VA healthcare
samples.
The Present Project
The purposes of the present project were 1) to evaluate the effectiveness of the
MOVE! weight management program for veterans with PTSD, 2) to assess the exerciserelated changes in PTSD symptoms, and 3) to assess differences in exercise behavior,
motivation, and attitudes between veterans with and without PTSD. Studies have shown a
relationship between PTSD and a number of physical health comorbidities, most notably
obesity and cardiovascular disease. PTSD has also been linked to health-risk behaviors,
including decreases in physical activity, alcohol use and smoking. Exercise has been
indicated as a treatment for PTSD and other psychological disorders and is an important
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component to weight loss treatments. The MOVE! weight management program has been
rolled out throughout the VA system and has shown to be effective in reducing body
weight among overweight and obese veterans. PTSD presents an added challenge to
weight loss as patients with PTSD may be less likely to engage in necessary behaviors
like exercise, although exercise can help to alleviate symptoms of PTSD and should be
conducted for successful weight loss. No studies have looked at the differential
effectiveness of the MOVE! weight management program for patients diagnosed with
PTSD. This study will also look at exercise related PTSD symptom decrease and
differences between exercise-related factors for patients with and without PTSD.
Hypotheses
Study 1
Study 1 used archival data from veterans who participated in the MOVE! program
at the Memphis VAMC over a 6-year period, derived from veterans’ electronic medical
records. This dataset was used to evaluate a set of hypotheses related to the impact of
PTSD diagnosis on MOVE! outcome.
Hypothesis 1: PTSD has been associated with a number of poor health behaviors
including physical inactivity, alcohol use, and smoking. Given that individuals with
PTSD are less likely to be physically active than their non-PTSD counterparts and a
tendency towards other negative health behaviors it is possible that PTSD patients in the
MOVE! program will have greater difficulty altering their exercise behaviors, which is a
core component of weight-loss, overall health, and the MOVE! program. PTSD
diagnoses will be obtained from the diagnostic problem list in their computerized patient
records. For each sub-hypothesis age, number of medical conditions (medical and
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psychological), number of weight increasing medications, and partner status were
controlled for as covariates
1a. We predicted that participants diagnosed with PTSD would have worse
outcomes subsequent to their participation in the MOVE! program compared to
non-PTSD participants as evidenced by smaller reductions in body weight at the
end of the MOVE! program, relative to baseline levels.
1b. We predicted that participants with PTSD would have worse outcomes
compared to non-PTSD participants at the end of participation in the MOVE!
program, relative to baseline levels, as measured by several physiological
indicators. Participants with PTSD would have higher blood pressure, cholesterol,
blood glucose levels, and respiratory rates relative to non-PTSD participants, at
the end of their participation in the MOVE! program, relative to baseline levels.
Study 2
The data for the following hypotheses were collected longitudinally from patients
in the Memphis VAMC’s ongoing MOVE! weight management program. Participants’
exercise behaviors and attitudes and health behaviors were assessed at 4 time points
(baseline, 4-week, 8-week, and 12-week).
Hypothesis 2: PTSD is marked by avoidance; this avoidance often becomes
pervasive and decreases the likelihood of engaging in activities and programs like
MOVE!. Individuals with PTSD tend to have high anxiety sensitivity, which is associated
with fear of engaging in exercise. This pronounced avoidance and high anxiety sensitivity
might cause MOVE! patients with PTSD to be less likely to engage in the MOVE!
program and to have more negative perceptions of exercise and the prospect of losing
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weight. Additionally, individuals with PTSD tend have a tendency to engage in
maladaptive coping behaviors, which may point to poor self-regulation and adoption of
coping behaviors incompatible with optimal improvement in the MOVE! program. For
each sub-hypothesis, alcohol use (AUDIT), smoking (FTND), and health related quality
of life were controlled for as covariates.
2a. We predicted that participants with diagnoses of PTSD (verified in their
medical record) would be more likely than non-PTSD veterans to drop out of
treatment prematurely (i.e., prior to 8 weeks), as measured by the number of
MOVE! group sessions attended.
2b. We predicted that participants with PTSD would engage in less exercise
behavior than non-PTSD participants as measured by the Godin Leisure Time
Exercise Questionnaire (LTEQ).
2c. We predicted that participants with PTSD would show lower motivation for
exercise than non-PTSD participants as evidenced by scores on the University of
Rhode Island Change Assessment – E2 (URICA-E2).
2d. We predicted that participants with PTSD would report more negative
perceptions of exercise than non-PTSD participants as evidenced by scores on the
Exercise Benefits/Barriers Scale (EBBS).
2e. We predicted that PTSD participants would have lower overall self-regulation
skills compared to non-PTSD participants as measured by the Short SelfRegulation Questionnaire (SSRQ).
Hypothesis 3: Exercise has been supported as a treatment for several mood and
anxiety disorders and emerging evidence suggests that exercise may be beneficial for
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individuals diagnosed with PTSD. We predicted that participants diagnosed with PTSD
who increase their exercise, in accordance with the goals of the MOVE! program, would
experience reductions in PTSD symptoms as measured lower scores on the PTSD
Checklist (PCL) scores during treatment in the MOVE! program.
Study 1: Archival data
The first study used archival data from veterans at the Memphis VAMC to test the
first hypothesis evaluating the comparative efficacy of the MOVE! weight management
program for PTSD and non-PTSD veterans on key outcomes: body weight, blood
pressure, glucose levels, respiratory rate, and cholesterol.
Method
Participants
Participants for this study were 920 patients who were enrolled in the MOVE!
weight management program between 2006 and 2012. Participants were referred to the
program by their primary care provider if they were overweight or obese (BMI ≥ 25).
Study subjects were predominantly male (n = 774; 84.1%) and the sample included 539
(58.6%) Black or African American, 316 (34.3%) White, 5 (.5%) American
Indian/Alaskan Native, 5 (.5%) Native Hawaiian/Pacific Islander, and 55 (6%)
participants of unknown ethnicity. Study subjects were largely male (n = 774; 84.1%).
Measures
Data for this study were retrieved from the Computerized Patient Record System
(CPRS) by data analysts at the Memphis VAMC including, PTSD diagnosis (based on
clinician evaluation), demographics, weight, body mass index, vital signs (i.e., blood
pressure and respiratory rate), laboratory tests (i.e., glucose levels and cholesterol),
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number of comorbid diagnoses (a tally of the number of physical and psychological
disorders was made based on patient’s “Problem list” in CPRS), and number of weight
increasing medications. Medications were considered “weight increasing” based on a list
maintained by VA pharmacists, which denotes medications and classes of medication
frequently associated with weight gain. Weight increasing effects were coded in the study
using this information. Data were extracted from 3 time points: 1) date of first
participation with the MOVE! Program; 2) date of last session in the MOVE! program;
and 3) 1 year after patient’s final session in the MOVE! program.
Procedure
Medical Chart Review. Archival data came from the Memphis VAMC
computerized patient record system. Participants had enrolled in the MOVE! weight
management program between 2006 and 2012 if they were overweight or obese.
Participants engaged in a multidisciplinary structured curriculum that contained nutrition,
physical activity, and psychological topics related to weight loss that met once a week in
a group format led by a health professional.
Study 2: Prospectively collected data
The second study used longitudinal data, collected at 4 time points to test the
second and third hypotheses, evaluating patient acceptance of the MOVE! program
treatment, clinically significant PTSD symptom improvement, and factors associated
with making the MOVE! treatment more powerful for patients with PTSD.
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Method
Participants
We recruited 32 veterans at the beginning of their participation in the MOVE!
program to participate in study 2. All veterans initiating participation in MOVE! group
sessions were eligible to participate in this study. MOVE! program participants were
approached at the beginning of MOVE! group sessions and were informed that
participation would consist of completing a brief packet of questionnaires at 4 time points
during their participation in the MOVE! program (baseline, 4-week, 8-week, and 12week). The MOVE! program is open to all patients in the VA system who are identified
as overweight or obese by their primary care physician and have no contraindications to
engaging in exercise behavior prescribed by the program. Participants were screened for
PTSD diagnosis using the PCL. The sample was predominantly male (n = 23; 71.9%) and
Caucasian (n = 19; 59.4%). The remainder of the sample (n = 13; 40.6%) self-identified
as black or African American.
Measures
PTSD
PTSD Checklist – Military Version (PCL-M; Weathers et al., 1993). The PCL-M
is a 17-item, self-report questionnaire in which participants indicate how much they have
been bothered by specific PTSD symptoms related to stressful military experiences over
the past month on a 5-point scale ranging from “not at all” to “extremely”. PCL-M items
correspond with the DSM-IV-TR diagnostic criteria for PTSD, assessing the 3 symptom
clusters of re-experiencing, avoidance and numbing, and hyperarousal. The PCL-M can
be used in several ways to evaluate PTSD symptomatology. PTSD symptoms can also be
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evaluated by summing scores on the 17 items to create a total severity score and
determining whether that total severity score exceeds the recommended cutoff score of 50
(Weathers et al., 1993). Scores on the PCL-M can range from 17 to 85. The PCL-M is
widely used and has shown good psychometric properties in veteran samples. The PCLM performed well in a sample of male Vietnam war veterans and showed good internal
consistency reliability (Full Scale: .97; Cluster B: .93; Cluster C: .92; Cluster D: .92),
test-retest reliability (.96), and convergent validity with the Mississippi Scale for
Combat-Related PTSD (.93) (Weathers et al., 1993). Psychometric properties of the
PCL-M were evaluated in another sample of male veterans and the PCL-M showed good
internal consistency reliability (Full Scale: .96; Cluster B: .94; Cluster C: .91; Cluster D:
.92), and convergent validity with the CAPS (.79) and the Mississippi Scale (.90) (Keen,
Kutter, Niles, & Krinsley, 2008).
Exercise Behavior and Attitudes
University of Rhode Island Change Assessment – E2 (URICA-E2; Lerdal et al.,
2009). The URICA-E2 is a 24-item measure assessing stage of change for regular
exercise. The URICA-E2 is based on the transtheoretical model of behavior change. The
model was described in the 1980s and was first applied to smokers assessing the process
of cessation and maintenance of cigarette use (DiClemente & Prochaska, 1982). The use
of the transtheoretical model has widened to describe stages of behavioral changes in
other areas including alcohol use and diet (DiClemente, Bellino, & Neavins, 1999;
Helitzer, Peterson, Sanders, & Thompson, 2007). A categorical stage of change measure
for physical activity has been developed and used in various studies (Marcus, Rossi,
Selby, Niaura, & Abrams, 1992; Blaney et al., 2012). Due to high rates of relapse in
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studies aiming to increase physical activity levels, the URICA-E2 was developed to more
accurately characterize the fluctuation and instability of motivation to perform exercise
activity. The URICA-E2 is a continuous measure in which respondents rate the degree to
which they are in different stages of change related to engaging in planned physical
activity. The URICA-E2 evaluates stage of exercise change behavior based on 6 stages.
Precontemplation non-believers and precontemplation-believers are defined as
individuals who are perceived as not having plans for beginning exercise behaviors in the
next 6 months. Those in the contemplation phase plan to change their exercise behavior
within the next 6 months. Individuals in the preparation phase plan to change their
exercise behavior within the next 30 days and have attempted the specific behavior
within the last year. Individuals in the action phase have been practicing the target
exercise behavior for the less than 6 months, and those in the maintenance phase have
practiced the behavior for more than 6 months. Participants endorse their attitude
regarding aspects of exercise on a 5-point Likert scale ranging from 1 (Strongly
Disagree) to 5 (Strongly Agree). The stages of change scales of the URICA-E2 have
shown good internal consistency in a sample of college students with subscale
reliabilities ranging from .72 to .92 (Lerdal et al., 2009).
Godin Leisure Time Exercise Questionnaire (LTEQ; Godin, Jobin, & Bouillon,
1986). The LTEQ is a 4-item self-report measure that assesses self-reported exercise
intensity. Participants are asked to indicate during a typical 7-day period how many times
on average they perform 3 different intensity levels of exercise for more than 15 minutes.
Strenuous exercise is described as exercise in which the heart beats rapidly. Respondents
are provided with examples of strenuous exercise activities (e.g., running, jogging,
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hockey, football, soccer, squash, etc.). Moderate exercise is described as exercise that is
not exhausting (e.g., fast walking, baseball, tennis, easy bicycling, volleyball, etc.). Mild
exercise is described as exercise that takes minimal effort (e.g., yoga, archery, fishing
from a river bank, bowling, golf, etc.). Participants are then asked to report how often
they engage in any regular activity long enough to work up a sweat in a typical 7-day
period. A composite exercise score is calculated using the weighted sum of each exercise
intensity according to the formula: (mild x 3) + (moderate x 5) + (strenuous x 9). The
LTEQ has shown to be both reliable and valid in a sample of adult males with a twoweek test-retest reliability of .64 and concurrent validities with values of maximum
oxygen uptake (VO2max: .38), body fat (.43), and muscular endurance (.54) (Godin et
al., 1986).
Exercise Benefits/Barriers Scale (EBBS; Sechrist & Walker, 1987). The EBBS is
a 43-item self-report measure, which prompts individuals to indicate their perceptions
concerning the benefits and barriers to participating in exercise on a 4-point Likert scale
ranging from 1 (Strongly Agree) to 4 (Strongly Disagree). The EBBS is made up of the
29-item benefits scale and the 14-item barriers scale. The benefits scale consists of items
like, “Exercise decreases feelings of stress and tension for me”. The barriers scale of the
EBBS contains items like, “Exercise takes too much time from my family
responsibilities”. Scores on the EBBS can range from 43 to 172, with higher scores
indicating more positive perceptions of exercise. The Exercise Benefits/Barriers Scale
has shown good reliability in a sample of community dwelling adults with a full-scale
internal consistency reliability of .95. The benefits and barriers scales showed internal
consistency reliabilities of .95 and .87 respectively. The full-scale of the EBBS has also
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shown good test-retest reliability in a sample of healthy adults at .89. The benefits and
barriers scales showed good test-retest reliabilities of .89 and .77 respectively.
Self-Regulation
Short Self-Regulation Questionnaire (SSRQ; Carey, Neal, & Collins, 2004). The
Short Self-Regulation Questionnaire is a 31-item self-report instrument developed to
assess one’s ability to regulate behavior in the service of achieving future-oriented
outcomes. The instrument contains items like “I don’t notice the effects of my actions
until it is too late” and “I don’t seem to learn from my mistakes”. Each item on the SSRQ
is scored on a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree), with
SSRQ total scores ranging from 31 to 153. The SSRQ has shown good internal
consistency reliability at .92 in a sample of 391 undergraduate students (Carey et al.,
2004).
Other Health-Related Measures
Alcohol Use Disorders Identification Test (AUDIT; Babor, Higgins-Biddle,
Saunders, & Monteiro, 2001). The Alcohol Use Disorders Identification Test is a 10-item
self-report instrument developed to screen for excessive drinking and to identify people
who would benefit from reducing or ceasing their alcohol consumption. The AUDIT
assesses the quantity and frequency of alcohol use, symptoms of alcohol dependence, and
alcohol related consequences. The AUDIT contains items like, “How often do you have a
drink containing alcohol?” Each of the AUDIT’s 10 items is scored on a 5-point Likert
scale from 0 to 4, with total AUDIT scores ranging from 0 to 40. A cutoff score of 8 or
more has been recommended for identifying hazardous or harmful levels of alcohol
consumption with good sensitivity and specificity (Babor et al., 2001). The AUDIT has
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shown good test-retest reliability at .86 in a mixed sample of non-hazardous drinkers,
cocaine abusers, and alcoholics (Babor et al., 2001). The AUDIT has also demonstrated
good test-retest reliability in a general practice sample of adults, applying the
recommended cutoff of 8, with 87.5% of those who screened positive at the first test also
being classified as positive at retest. A median internal consistency reliability of .83
(Reinert & Allen, 2006) has been found across 18 studies published since 2002.
Fagerstrom Test for Nicotine Dependence (FTND; Heatherton, Kozlowski,
Frecker, & Fagerstrom, 1991). The FTND is a 6-item measure assessing level of nicotine
dependence in cigarette smokers. The FTND is a revision of the Fagerstrom Tolerance
Questionnaire (FTQ: Fagerstrom, 1978), an 8-item measure of dependency on nicotine.
The FTQ was reviewed due to psychometric deficiencies. The FTQ was shown to have
low internal consistency reliability in two adult smoker samples (alphas: .55; .51). The
FTND was developed out of the FTQ to better predict biochemical measures of heaviness
of smoking. Items on the Fagerstrom Test for Nicotine Dependence are scored on a 4point Likert scale from 0 to 3 or as “Yes” or “No”. Respondents to the FTND answer
questions like, “How soon after you wake up do you smoke your first cigarette?” and “Do
you smoke if you are so ill that you are in bed most of the day?” Scores on this measure
can range from 0 to 10. In a sample of healthy adults the FTND has shown good internal
consistency reliability at .61 (Heatherton et al., 1991). The FTND has also been evaluated
in smokers diagnosed with PTSD and was reliable and valid in this population. The
FTND showed a test-retest reliability coefficient of .82 and showed convergent validity
with respect to CO levels (.40), with milligrams of nicotine per day (.38), and with the
Smoking Withdrawal Questionnaire (.37). The FTND was factor analyzed in this sample
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and showed similar patterns to other investigations, resulting in a two-factored structure
with questions targeting heaviness of smoking and morning smoking (Buckley et al.,
2005).
Health Related Quality of Life (HRQOL; Mielenz et al., 2006). The HRQOL is a 9item measure developed by the Center for Disease Control for the purposes of measuring
a population’s general well-being. This version of the HRQOL includes the 4-item
Healthy Days Core Module and the 5-item Healthy Days Symptoms Module. The
HRQOL assesses the effects and interference of physical health and chronic illness in a
person’s every day life. The first item assesses self-rated general health with five
responses ranging from poor to excellent. Scores on the rest of the items of the HRQOL
range from 0 to 30, with higher scores indicating worse perceived health. The Healthy
Days Core Module assesses a person’s perceived well-being in the past 30 days. The
Healthy Days Symptoms Module of the HRQOL items ask about the number of days in
the past month the patient has experienced particular health-related conditions or
problems (i.e., pain, depression, anxiety, sleeplessness, and low energy). The Healthy
Days Core Module of the HRQOL has shown to be 2-week test-retest reliability in a
community sample of adults with retest reliabilities ranging from .58 to .75 (Andresen,
Catlin, Wyrwich, & Jackson-Thompson, 2003). Principle component analysis of the
Healthy Days Core and Symptoms Modules points to a two-factor structure, which
comprised a physical health scale and mental health scale. The factors of the HRQOL
showed good internal consistency reliability in a sample of adults with arthritis with
alpha coefficients of .84 (physical health) and .91 (mental health) (Mielenz, Jackson,
Currey, DeVellis, & Callahan, 2006) Each item of the HRQOL was entered as a covariate
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in the following analyses, those items not contributing significantly to the model were
removed.
Procedure
Questionnaire data collection. All veterans participating in their first group
session of the MOVE! weight management program at the Memphis VAMC were
approached and asked of their interest in the study. The researcher explained procedures,
potential risks and benefits, voluntary participation, and confidentiality. If the veteran
indicated interest in participating, written informed consent for participation and contact
information were obtained, and the first assessment packet was given to the veteran.
Participants were asked to complete the first assessment packet and to direct any
questions to the researcher. The assessment packet consisted of 11 self-report
questionnaires. No compensation was provided for completion of the questionnaires. The
process of informed consent and completion of the first questionnaire packet took
approximately 20 minutes. Participants were allocated to the PTSD group or non-PTSD
group based on PCL scores. Following completion of the first assessment packet, the
researcher contacted participants by phone or email prior to subsequent 4-week, 8-week,
and 12-week assessments. Participants were given the same battery of questionnaires to
complete at each of the 3 subsequent time points.
Data Analysis Plan
Study 1
To test hypothesis 1, analyzing the differences between PTSD and non-PTSD
participants on weight and weight-related outcomes, hierarchical linear models were
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conducted to test whether each MOVE! outcome measure retrieved from the Memphis
VAMC computerized patient record system varied over time by PTSD status.
1a. Body weight at baseline, at MOVE! program completion, and at 1-year post
completion were regressed on PTSD diagnosis, while controlling for potential
confounders: age, partner status, number of weight increasing medications, and
comorbid diagnoses. After running the initial full model, covariates that did not
significantly contribute to the model were removed.
1b. Physiological indicators (blood pressure, cholesterol levels, blood glucose
levels, and respiratory rates) at baseline, MOVE! program completion, and 1-year
post completion were regressed on PTSD diagnosis, while controlling for
potential confounders: age, partner status, number of weight increasing
medications, and comorbid diagnoses (mental and physical). After running the
initial full model, covariates that did not significantly contribute to the model
were removed.
Study 2
To test hypothesis 2, analyzing differences in dropout between PTSD and nonPTSD participants a chi-square test was run.
2a. PTSD status (PTSD/non-PTSD) was entered into the test as the independent
variable while dropout status (dropout/completer) was entered as the dependent
variable. Differences in dropout by group were determined by chi-square value
and standardized residuals. The standardized residual gives an indication of the
distance between the expected count of a cell and the observed count. To test
whether exercise and exercise-related variables varied over time for groups with
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and without PTSD, separate hierarchical linear models were tested for each
outcome.
To test the exercise components of hypothesis 2, hierarchical linear models were
conducted for exercise behavior, motivation, attitudes, and self-regulation.
2b. Exercise behavior score (baseline, 4-week, 8-week, 12-week: LTEQ) was
regressed on PTSD diagnosis, while controlling for potential confounders: alcohol
use (AUDIT), smoking (FTND), and health related quality of life (HRQOL).
After running the initial full model, covariates that did not significantly contribute
to the model were removed.
2c. Motivation to exercise scores (baseline, 4-week, 8-week, 12-week: URICAE2) were regressed on PTSD diagnosis, while controlling for potential
confounders: alcohol use (AUDIT), smoking (FTND), and health related quality
of life (HRQOL). After running the initial full model, covariates that did not
significantly contribute to the model were removed.
2d. Exercise attitude scores (baseline, 4-week, 8-week, 12-week: EBBS) were
regressed on PTSD diagnosis, while controlling for potential confounders: alcohol
use (AUDIT), smoking (FTND), and health related quality of life (HRQOL).
After running the initial full model, covariates that did not significantly contribute
to the model were removed.
2e. Self-regulation score (baseline, 4-week, 8-week, 12-week: SSRQ) was
regressed on PTSD diagnosis, while controlling for potential confounders: alcohol
use (AUDIT), smoking (FTND), and health related quality of life (HRQOL).
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After running the initial full model, covariates that did not significantly contribute
to the model were removed.
To test hypothesis 3, analyzing exercise related changes in PTSD symptoms
(PCL) of study participants, we ran hierarchical linear models where PTSD symptoms
were regressed upon physical activity.
Results
Study 1
In the archival data sample, patient chart review showed that 21.7% (n = 200) of
the sample of participants in the MOVE! program had a diagnosis of PTSD in their VA
medical record. The sample was comprised of Vietnam era (n = 470; 51.1%), PostVietnam (n = 205; 22.3%), Persian Gulf (n = 188; 20.4%), Korean War (n = 21; 2.3%),
Post-Korean War (n = 19; 2.1%), World War II (n = 13; 1.4%), Pre-Korean (n = 2; .2%),
and two veterans (.2%) of an unknown era. The mean age of participants was 60.59 (yrs).
The mean number of comorbid diagnoses (mental and physical health) in the sample was
19.79. The most common conditions fell in the ICD category of endocrine, nutritional,
and metabolic disorders with 92.5% of the sample carrying at least one diagnosis. Mental
health conditions were also highly prevalent in the sample, with 70.5% of the sample
carrying at least one mental health condition. The mean number of prescribed
medications with weight-increasing side effects was .95. In the sample, 796 (86.6%)
participants completed fewer than 12 sessions in the program. 636 (69.1%), 633 (68.8%),
and 489 (53.1%) participants provided weight, systolic blood pressure, and diastolic
blood pressure data at baseline, end of treatment, and 1-year follow-up respectively. 82
(8.9%), 13 (1.4%), and 81 (8.8%) participants provided cholesterol data at baseline, end
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of treatment, and 1-year follow up respectively. 691 (75.1%), 690 (75.0%), and 481
(52.3%) participants provided blood serum glucose data at baseline, end of treatment, and
1-year follow-up respectively. 635 (69.0%), 624 (67.8%), and 484 (52.6%) participants
provided respiratory data at baseline, end of treatment, and 1-year follow-up respectively.
There was a statistically significant reduction in weight over time in the sample where the
mean baseline, end of MOVE!, and follow-up weight (lbs) of participants were 249.90,
247.60 and 247.52 respectively (See Table 1). There were no statistically significant
differences between the PTSD and Non-PTSD groups at baseline.
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Table 1 (Archival: Total N = 920) 1
Baseline, End of Treatment, and 1-year Follow-up Outcome Measures
Vital Signs/Labs
Beginning of MOVE!
End of MOVE!
M (SE)
M (SE)

1 year follow-up
M (SE)

p

Weight
249.90 (9.16)
247.60 (9.16)
247.52 (9.16)
< .05
Systolic Blood Pressure
134.11(.771)
133.25(.771)
133.61(.84)
.61
Diastolic Blood Pressure
76.69(1.31)
75.74(1.32)
75.46(1.33)
.07
Respiratory Rate
18.84(.07)
18.79(.07)
18.77(.08)
.75
Glucose
118.85(1.02)
116.68(1.02)
117.22(1.02)
.62
Cholesterol
100.36(4.47)
95.73(8.06)
94.88(4.53)
.42
Note. Reported are predicted means and SE, which are estimated from the fitted model
1
Weight, Systolic BP, Diastolic BP: N = 636; Respiratory Rate: N = 635; Glucose: N = 691; Cholesterol: N = 82

Table 2 (Archival: Total N = 920) 1
Baseline, End of Treatment and 1-year follow-up Outcomes for PTSD and non-PTSD participants
Vital
Beginning of MOVE! M
p
End of MOVE! M (SE)
p
1 year follow-up M (SE)
Signs/Labs
(SE)
PTSD
Non-PTSD
PTSD
Non-PTSD
PTSD
Non-PTSD
Weight
246.53(9.90) 253.28(9.07) .18 244.34(9.90)
250.87(9.07) .19 244.24(9.92) 250.80(9.08)
Systolic
134.33(1.35)
133.89(.74) .78 133.56(1.35)
132.95(.75)
.69 133.78(1.46)
133.44(.84)
Blood
Pressure
Diastolic
77.37(1.48)
76.01(1.30) .14
76.57(1.48)
74.91(1.30)
.07 75.99(1.52)
74.93(1.32)
Blood
Pressure
Respiratory
18.68(.13)
19.01(.07)
.03
18.68(.13)
18.91(.07)
.15
18.72(.14)
18.81(.08)
Rate
Glucose
121.06(1.03) 116.41(1.02) .26 118.03(1.03)
115.35(1.02) .52 116.14(1.04) 118.03(1.02)
Cholesterol 103.10(7.81)
97.62(4.42) .54 100.09(14.68)
91.37(6.72)
.59 95.79(7.95)
93.97(4.42)
Note. Reported are predicted means and SE, which are estimated from the fitted model
1
Weight, Systolic BP, Diastolic BP: N = 636; Respiratory Rate: N = 635; Glucose: N = 691; Cholesterol: N = 82
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.20
.84

.30

.69
.66
.84

	
  

Table 3 (Archival Data: N = 920)
Correlations Between Covariates and Baseline Dependent Variable
Weight Systolic Diastolic BP
Respiratory
BP
Rate

Cholesterol

Glucose

Age

.03

.07

-.24**

.09*

-.29**

.10*

# Health Conditions
(Mental and Physical)

.07

.05

.01

.03

-.10

.10**

Weight Increasing
Medication

.07

.04

-.01

.07

-.07

.12**

*p < .05
**p < .01

Table 4 (Archival Data: N = 920)
PTSD and Non-PTSD Group Descriptives
PTSD (N = 200)
M (SD)
Age
57.66 (10.47)
% Service Connected
70.00 (32.47)
# Move Sessions
6.67 (8.55)
Total # Medical Conditions
20.79 (10.02)
Gender
Male
Female
Partner Status
Never Married
Married
Divorced
Separated
Widowed
Unknown
Race
Black/African American
White (Not Hispanic)
American Indian
Native Hawaiian
Unknown

Non-PTSD (N = 720)
M (SD)
60.10 (10.88)
31.82 (37.84)
7.18 (15.49)
17.18 (9.91)

N (%)

N(%)

165 (82.50)
35 (17.50)

609 (84.60)
111 (15.40)

20 (10.00)
107 (53.50)
53 (26.50)
13 (6.50)
7 (3.50)
0 (0.00)

121 (16.80)
324 (45.00)
195 (27.10)
51 (7.10)
27 (3.80)
2 (.30)

122 (61.00)
64 (32.00)
4 (2.00)
4 (2.00)
6 (3.00)

417 (57.90)
252 (35.00)
1 (.10)
1 (.10)
49 (6.80)
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Weight. First, we examined the impact of PTSD diagnosis on weight trajectories
for program participants. To test hypothesis 1a, assessing differences in weight changes
for the PTSD and non-PTSD group, we conducted hierarchical linear models to analyze a
data structure where repeated weight scores (level-1) were nested within participants and
PTSD diagnosis (level-2). The full model was run controlling for age, partner status,
number of weight increasing medications, and comorbid diagnoses. Non-significant
covariates were then removed from the final model leaving only partner status. After
controlling for partner status, PTSD diagnosis was not predictive of weight trajectory.
There was a main effect for Time (F(1, 555.88) = 3.63, p < .05) such that at time 1 (M =
249.90, SE = 9.16) participants weighed more than at time 2 (M = 247.60, SE = 9.16) and
time 3 (M = 247.52, SE = 9.16). The PTSD x Time interaction was not significant.
Partner status was associated with weight (F(5,628.35) = 3.21, p < .01) such that at Time
1 married participants (M = 259.96; SE = 3.19) weighed more than never married (M =
242.27; SE = 5.66), divorced (M = 244.64; SE = 4.25), and widowed (M = 236.97; SE =
10.50) participants.
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Figure 1. Trajectories of participant weight over time.

Table 5 (Archival Data: N = 636)
Weight Change in the MOVE! Program
Variable
γ
Intercept
246.03
PTSD
.
Non-PTSD
6.56
Time 1
2.29
Time 2
.10
Time 3
.
PTSD*Time 1
.20
PTSD*Time 2
-.03
PTSD*Time 3
.
Never Married
-7.86
Married
9.82
Separated
5.93
Divorced
-5.50
Widowed
-13.17
Unknown
.

t
4.72
.
1.29
1.18
.06
.
.09
-.02
.
-.15
.19
.11
-.11
-.25
.

df
624.74
.
689.80
689.80
689.80
.
689.80
689.80
.
624.17
624.11
624.25
624.13
624.22
.

p
<. 01
.
.20
.24
.95
.
.93
.99
.
.88
.85
.91
.92
.80
.

Vital Signs. Next, we tested hypothesis 1b, evaluating the effects of PTSD
diagnosis on the trajectories of vital signs for MOVE! program participants. To assess
differences in blood pressure changes for PTSD and non-PTSD participants in the
MOVE! program we first conducted hierarchical linear models to analyze a data structure
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where repeated systolic blood pressure measurements (level-1) were nested within
participants and PTSD diagnosis (level-2). After controlling for age, there was neither a
main effect for PTSD diagnosis, Time, nor the PTSD x Time interaction.

Figure 2. Trajectories of participant systolic blood pressure over time.

Table 6. (Archival Data: N = 636)
Systolic BP Change in the MOVE! Program
Variable
γ
Intercept
127.72
PTSD
.
Non-PTSD
-.33
Time 1
.55
Time 2
-.22
Time 3
.
PTSD*Time 1
-.10
PTSD*Time 2
-.28
PTSD*Time 3
.
Age
.10

t
38.78
.
-.20
.34
-.14
.
-.05
-.15
.
1.98

Df
743.85
.
1552.11
1156.23
1156.23
.
1161.79
1161.25
.
624.79

p
<. 05
.
.84
.73
.89
.
.96
.88
.
< .05

Secondly, we conducted hierarchical linear models analyzing a data structure
where diastolic blood pressure scores (level-1) were nested within participants and PTSD
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diagnosis (level-2). After controlling for partner status and age, there was not a main
effect for PTSD diagnosis or Time and the PTSD x Time interaction was not significant.
Partner status was predictive of diastolic blood pressure (F(5,605.69) = 2.49, p < .05)
such that married participants (M = 74.48; SE = .45) had lower diastolic blood pressures
than never married (M = 77.07; SE = .84) and widowed participants (M = 77.96; SE =
1.49). Age was predictive of changes in diastolic blood pressure such that older age was
associated with lower diastolic blood pressure (See Table 7).
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Figure 3. Trajectories of participant diastolic blood pressure over time.

Table 7 (Archival Data: N = 636)
Diastolic BP Change in the MOVE! Program
Variable
γ
Intercept
86.37
PTSD
.
Non-PTSD
-1.05
Time 1
1.38
Time 2
.58
Time 3
.
PTSD*Time 1
-.31
PTSD*Time 2
-.60
PTSD*Time 3
.
Never Married
2.43
Married
-.16
Separated
1.58
Divorced
.76
Widowed
3.32
Unknown
.
Age
-.19

t
11.55
.
-1.04
1.38
.58
.
-.27
-.52
.
.33
-.02
.22
.11
.45
.
-6.19

df
580.26
.
1592.12
1157.92
1157.92
.
1164.02
1163.46
.
571.13
570.64
571.80
570.85
571.64
.
611.04

p
<. 01
.
.30
.17
.56
.
.79
.60
.
.74
.98
.83
.92
.65
.
<. 01

We then evaluated the relationship between PTSD diagnosis and changes in
respiratory rates for MOVE! program participants. To assess for differences in respiration
between the PTSD and non-PTSD group, we conducted hierarchical linear models to
analyze a data structure where repeated respiratory rate measurements (level-1) were

	
  

56	
  

	
  
nested within participants and PTSD diagnosis (level-2). After controlling for weight and
age, the PTSD diagnosis main effect approached statistical significance (F(1, 610.27) =
3.78, p = .052), with PTSD participants having a lower mean respiration rate than nonPTSD participants. Time did not show a main effect and the PTSD x Time interaction
was not significant. Age was predictive of respiratory rates such that older age was
associated with higher respiratory rates.

Figure 4. Trajectories of participant respiration over time.

Table 8 (Archival Data: N = 635)
Respiratory Change in the MOVE! Program
Variable
γ
Intercept
16.78
49.97
PTSD
.
.
Non-PTSD
.06
.40
Time 1
-.05
-.27
Time 2
-.04
-.22
Time 3
.
.
PTSD*Time 1
.24
1.24
PTSD*Time 2
.15
.74
PTSD*Time 3
.
.
Weight
.004
5.14
Age
.02
3.78

	
  

t

df
780.27
.
1693.77
1161.22
1169.40
.
1168.94
1174.35
.
711.31
616.42
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p
< .01
.
.69
.79
.83
.
.22
.46
.
< .01
< .01

	
  
Laboratory Tests. Next, we evaluated the impact of PTSD diagnosis on the
trajectories of standard laboratory studies included in workups for overweight and obese
individuals. To assess differences in cholesterol changes between PTSD and non-PTSD
participants we conducted hierarchical linear models to analyze a data structure where
repeated cholesterol levels (level-1) were nested within participants and PTSD diagnosis
(level-2). After controlling for age, there was not a main effect for PTSD diagnosis or
Time and the PTSD x Time interaction. Age was predictive of cholesterol such that older
age was associated with lower cholesterol (See Table 8).
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Figure 5. Trajectories of participant cholesterol over time.

Table 9 (Archival Data: N = 82)
Cholesterol Change in the MOVE! Program
Variable
γ
Intercept
165.32
PTSD
.
Non-PTSD
-1.81
Time 1
7.32
Time 2
4.31
Time 3
.
PTSD*Time 1
-3.67
PTSD*Time 2
-6.91
PTSD*Time 3
.
Age
-1.11

t
6.98
.
-.20
.98
.32
.
-.43
-.47
.
-2.99

df
83.82
.
120.94
120.94
120.94
.
120.94
120.94
.
79.59

P
< .05
.
.84
.33
.75
.
.67
.64
.
< .01

To assess differences in blood serum glucose levels between PTSD and nonPTSD participants we conducted hierarchical linear models to analyze a data structure
where repeated glucose levels (level-1) were nested within participants and PTSD
diagnosis (level-2). After controlling for age, number of medications with weight
increasing side effects, and number of comorbid diagnoses, there were no main effects
for PTSD diagnosis or Time and the PTSD x Time interaction was not significant. Age,
weight increasing medications, and number of comorbid diagnoses were predictive of
higher blood glucose levels.
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Figure 6. Trajectories of participant blood serum glucose levels over time.

Table 10 (Archival Data: N = 691)
Glucose Change in the MOVE! Program
Variable
γ
Intercept
1.93
PTSD
.
Non-PTSD
.01
Time 1
.02
Time 2
.01
Time 3
.
PTSD*Time 1
-.02
PTSD*Time 2
-.02
PTSD*Time 3
.
Age
.001
Weight Increasing
.01
Drugs
Comorbid Diagnoses
.002

t
61.36
.
.44
1.00
.42
.
-1.17
-.94
.
3.25
3.59

df
9250.69
.
1530.90
1530.90
1530.90
.
1530.90
1530.90
.
749.83
723.25

p
< .01
.
.66
.32
.67
.
.24
.35
.
< .01
< .01

3.48

729.09

< .01

Study 2
In Study 2, we collected data from a sample of VA patients who were
participating in the MOVE! program at the Memphis VAMC. Participants completed the
PCL-M at each follow-up and a baseline score of 50 was used as a cutoff for screening
positive for PTSD. 32 individuals participated in total, with 14 participants (45.2%)
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screening positive for PTSD in study 2. Five participants (15.6%) completed all 4
assessments, 7 participants (21.9%) completed 3 assessments, 9 participants (28.1%)
completed 2 assessments, and the majority of the sample (n = 11; 34.4%) completed only
one assessment. For the purpose of analyses, the completion of at least 3 assessments (n =
12; 37.5%) was used as study completion. The sample from study 2 did not show
statistically significant changes in weight over time with a mean baseline weight of
235.95. Additionally, the PTSD main effect and the PTSD x Time interaction on
participants’ weights were not statistically significant.

	
  

61	
  

	
  

Table 11 (Prospective Data)
PTSD and Non-PTSD Group Descriptives
PTSD (N = 14)
M (SD)
Age
50.21 (11.52)
# Children
2.50 (1.88)

Non-PTSD (N = 17)
M (SD)
52.81 (11.29)
2.35 (1.46)

N (%)

N(%)

9 (64.3)
3 (21.4)

11 (64.70)
6 (35.30)

2 (14.30)
1 (7.10)
4 (28.60)
3 (21.40)
2 (14.30)

2 (11.80)
2 (11.80)
6 (35.3)
2 (11.80)
5 (29.4)

8 (57.10)
6 (42.90)

10 (58.80)
7 (41.20)

0 (0.00)
2 (14.30)
2 (14.30)
6 (42.90)

3 (17.60)
2 (11.80)
1 (5.90)
9 (52.90)

1 (7.10)
6 (42.90)
4 (28.60)
0 (0.00)

2 (11.80)
8 (47.10)
3 (17.60)
3 (17.60)

Gender
Male
Female
Partner Status
Single
Monogamous Relationship
Married
Separated
Divorced
Race
Black/African American
White (Not Hispanic)
Employment
Full-Time
Part-Time
Looking for Work
Not Looking for Work
Education
High school/GED
Some College
College
Beyond College
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Table 12 (Prospective Data: Total N = 32)
Baseline, 4-week, 8-week, and 12-week data Outcome Measures
Behavioral
Baseline
4-week
8-week
Measures
M (SE)
M (SE)
M (SE)
Weight
235.95 (8.43)
246.77 (10.08) 239.89 (17.21)
LTEQ

12-week
M (SE)
245.37 (10.98)

p
.62

11.73 (5.03)

16.48 (5.60)

9.69 (8.85)

13.00 (6.56)

.90

1.46 (.13)

1.34 (.17)

1.21 (.25)

1.40 (.19)

.76

10.84 (9.72)

15.72 (12.67)

39.75 (20.04)

13.82 (14.89)

.63

Moderate Days of
Exercise

1.55 (.14)

1.57 (.18)

1.54 (.25)

1.54 (.22)

1.00

Moderate Minutes
of Exercise

31.92 (14.12)

27.37 (17.36)

47.43 (26.91)

28.91 (20.97)

.91

Strenuous Activity

1.53 (1.14)

2.10 (1.17)

2.47 (1.30)

1.18 (1.22)

< .05

Stage of Change
(Preparation)

10.41 (.74)

10.21 (1.10)

11.21 (1.50)

9.97 (1.12)

.92

Stage of Change
(Action)

9.21 (.87)

8.91 (1.33)

9.41 (1.71)

8.12 (2.12)

.84

Stage of Change
(Maintenance)

9.15 (.77)

9.08 (1.22)

9.40 (1.46)

9.31 (1.23)

1.00

Exercise Barriers

27.76 (1.31)

26.36 (1.50)

31.61 (2.71)

26.05 (2.79)

.28

Vigorous Days of
Exercise
Vigorous Minutes of
Exercise

Self-Regulation
104.54 (2.84)
106.85 (3.17)
102.89 (3.82)
102.29 (3.90)
.55
Note. Reported are predicted means and SE, which are estimated from the fitted model
1
LTEQ: N = 26; Vigorous Exercise Days: N = 30; Vigorous Exercise Minutes: N = 30; Moderate Exercise
Days: N = 28; Moderate Exercise Minutes: N = 30; Strenuous Activity: N = 31; Exercise Motivation
(Preparation): N = 30; Exercise Motivation (Action): N = 28; Exercise Motivation (Maintenance): N = 28;
EBBS: N = 23; SSRQ: N = 29
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Table 13 (Prospective Data: Total N = 32)
Baseline, 4-week, 8-week, and 12-week Outcomes for PTSD and non-PTSD participants
Behavioral
Baseline
4-week
Measures
M (SE)
M (SE)

8-week
M (SE)

12-week
M (SE)

PTSD

Non-PTSD

p

PTSD

Non-PTSD

p

PTSD

Non-PTSD

p

PTSD

Non-PTSD

p

15.96(7.92)

7.50(6.21)

.40

21.13(6.46)

11.83(9.14)

.41

17.16(7.92)

2.21(15.83)

.40

21.19(8.46)

4.81(10.01)

.22

1.61(.20)

1.31(.18)

.28

1.54(.20)

1.14(.27)

.23

1.39(.24)

1.02(.45)

.48

1.36(.25)

1.44(.29)

.83

9.43(14.69)

12.25(12.74)

.89

16.53(14.69)

14.92(20.65)

.95

79.28(17.93)

.22(35.86)

.05

8.49(19.21)

19.16(22.76)

.72

1.77(.22)

1.34(.20)

.17

1.92(.22)

1.22(.28)

.06

1.58(.24)

1.50(.44)

.88

1.72(.29)

1.37(.35)

.47

Moderate
Minutes of
Exercise

28.57(20.94)

35.27(18.94)

.81

26.24(20.94)

28.50(27.69)

.95

83.48(24.65)

11.38(47.84)

.19

35.16(26.91)

22.66(32.15)

.77

Days of
Strenuous
Activity

1.58(1.21)

1.48(1.19)

.80

2.33(1.22)

1.91(1.28)

.54

2.37(1.27)

2.57(1.59)

.88

1.29(1.28)

1.07(1.36)

.63

Stage of Change
(Preparation)

10.95(1.12)

9.88(.98)

.51

9.75(1.12)

10.68(1.90)

.58

9.51(1.35)

12.91(2.67)

.17

10.00(1.44)

9.94(1.70)

.99

Stage of Change
(Action)

12.18(1.34)

6.23(1.32)

<.01

13.42(1.41)

4.39(2.42)

<.01

11.90(1.50)

6.92(3.10)

.16

8.79(1.66)

7.44(3.92)

.76

Stage of Change
(Maintenance)

11.53(1.23)

6.77(1.13)

<.01

11.97(1.26)

6.18(2.14)

<.05

11.18(1.35)

7.62(2.62)

.18

10.63(1.65)

8.00(2.04)

.56

Exercise
Barriers
Self-Regulation

28.36(1.86)

27.15(1.82)

.65

27.71(1.81)

25.02(2.39)

.38

28.47(2.05)

34.75(5.02)

.26

28.72(2.19)

23.38(5.11)

.35

101.16(4.07)

107.93(3.94)

.24

99.33(4.10)

114.36(4.85)

<.05

103.25(4.51)

102.53(6.17)

.93

104.31(5.20)

100.27(5.82)

.61

LTEQ
Vigorous Days
of Exercise
Vigorous
Minutes of
Exercise
Moderate Days
of Exercise

Note. Reported are predicted means and SE, which are estimated from the fitted model
1

LTEQ: N = 26; Vigorous Exercise Days: N = 30; Vigorous Exercise Minutes: N = 30; Moderate Exercise Days: N = 28; Moderate Exercise Minutes: N = 30; Strenuous Activity: N = 31; Exercise
Motivation (Preparation): N = 30; Exercise Motivation (Action): N = 28; Exercise Motivation (Maintenance): N = 28; EBBS: N = 23; SSRQ: N = 29
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Table 14 (Prospective Data: N = 32)
Correlations Between Covariates and Baseline Dependent Variable
LTEQ Days
Days
Minutes
Minutes
Vigorous Moderate Vigorous Moderate
Exercise Exercise
Exercise
Exercise
AUDIT
.36
.03
.01
.25
.19
FTND

Strenuous
Activity

Exercise
Motivation
(Action)
.01

Exercise
Motivation
(Maintenance)
.07

EBBS

SSRQ

.29

Exercise
Motivation
(Preparation)
.06

-.48*

.41*

-.14

-.22

-.21

.24

.22

.20

.37

.08

.08

-.16

.10

Days Limited
-.07
by
Mental/Physical
Health
(HRQOL)
Days Limited
-.05
by Pain
(HRQOL)
*p < .05 **p < .01

-.09

-.28

-.15

-.06

.07

.24

.02

-.18

.32

-.22

-.03

-.33

-.32

-.26

-.03

.21

-.06

-.14

.35

-.41
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Attrition. We evaluated the probability of attrition from study 2 based on a
positive screening for PTSD. To test this hypothesis (2a) where we analyzed the
differences in dropout between participants who screened positive and negative for
PTSD, we conducted Chi-square tests of significance with PTSD status as the
independent variable and dropout as the dependent variable. Using the completion of at
least 3 time points in this study as the standard for completion, there was not a significant
difference between the positive and negative PTSD screen groups in terms of dropout
χ2(1, N = 31) = 3.66, p = .06, however the trend suggests that those with more PTSD
symptoms showed a lower rate of attrition than participants screening negative for PTSD.
The difference between completer (M = 230.94; SD = 42.24) and non-completer (M =
241.73; SD = 56.71) weights at baseline was not statistically significant (t(25) = .54, p =
.60).

Table 15 (N = 31)
Participant Attrition
Variable

Completer (%)

Non-Completer (%)

PTSD Negative

4 (23.5%)

13 (76.5%)

PTSD Positive

8 (57.1%)

6 (42.9%)

Exercise Behavior. Next, we tested hypothesis 2b, where we evaluated the
impact of PTSD symptoms on changes in exercise behavior over time. To test our
hypothesis assessing differences in general physical activity levels between the PTSD
and non-PTSD group, we conducted hierarchical linear models to analyze a data structure
where participant physical activity levels (level-1) were nested within participants and
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PTSD diagnosis (level-2). There was no main effect for PTSD screen or Time and the
PTSD x Time interaction was not statistically significant.

Figure 7. Trajectories of general physical activity levels over time.

Table 16 (Prospective Data: N = 26)
Exercise Behavior (LTEQ) of Program Participants
Variable
Coefficient
t
Intercept
21.19
2.50
PTSD
.
.
Non-PTSD
-16.38
-1.25
Time 1
-5.24
-.45
Time 2
-.058
-.01
Time 3
-4.03
-.35
Time 4
.
.
PTSD Diagnosis*Time 1
7.92
.48
PTSD Diagnosis*Time 2
7.08
.41
PTSD Diagnosis*Time 3
1.43
.07
PTSD Diagnosis*Time 4
.
.

df
53.00
.
53.00
46.30
41.44
39.88
.
46.03
44.31
48.50
.

p
< .05
.
.22
.65
.99
.73
.
.64
.68
.95
.

We then shifted our focus to the frequency and total amounts of different
intensities of physical activity, we evaluated the effect of PTSD symptoms on
engagement in vigorous and moderate physical activity over time. To assess for
differences in the number of days and the total number of minutes of vigorous and
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moderate physical activity during a typical week (past month) between the positive and
negative PTSD screen groups we conducted hierarchical linear models to analyze a data
structure where four separate models were created for number of days and number of
minutes of vigorous and moderate exercise (level-1) were each nested within participants
and PTSD diagnosis (level-2). There were no main effects for PTSD, or Time and the
PTSD x Time interaction was not statistically significant for number of days of vigorous
exercise or number of minutes of vigorous exercise in the past month (see Tables 16 and
17). There were no main effects for PTSD diagnosis or Time and the PTSD x Time
interaction was not significant for either number days or number of minutes of moderate
exercise (see Tables 18 and 19). The HRQOL control variable, number of days of
physical/mental health limitation was predictive of fewer days of moderate exercise.
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Figure 8. Trajectories of number of days of vigorous activity over time.

Table 17 (Prospective Data: N = 30)
Number of Days in the Past Month of Vigorous Exercise
Variable
Coefficient
t
Intercept
1.36
5.43
PTSD
.
.
Non-PTSD
.08
.21
Time 1
.25
.93
Time 2
.19
.70
Time 3
.03
.11
Time 4
.
.
PTSD Diagnosis*Time 1
-.37
-.93
PTSD Diagnosis*Time 2
-.49
-1.11
PTSD Diagnosis*Time 3
-.44
-.77
PTSD Diagnosis*Time 4
.
.
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df
59.87
.
59.92
41.39
38.93
38.12
.
43.24
41.42
44.93
.

p
< .01
.
.83
.36
.49
.91
.
.36
.27
.45
.

	
  

Figure 9. Trajectories of number of minutes of vigorous activity over time.

Table 18 (Prospective Data: N = 30)
Number of Minutes of Vigorous Exercise in the Past Month
Variable
Coefficient
t
Intercept
8.49
.44
PTSD
.
.
Non-PTSD
10.66
.36
Time 1
.94
.04
Time 2
8.04
.34
Time 3
70.79
2.88
Time 4
.
.
PTSD Diagnosis*Time 1
-7.84
-.22
PTSD Diagnosis*Time 2
-12.28
-.32
PTSD Diagnosis*Time 3
-89.73
-1.86
PTSD Diagnosis*Time 4
.
.
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df
59.41
.
59.41
59.41
59.41
59.41
.
59.41
59.41
59.41
.

p
.66
.
.72
.97
.74
.01
.
.83
.75
.07
.

	
  

Figure 10. Trajectories of number of days of moderate activity over time.

Table 19 (Prospective Data: N = 28)
Number of Days in the Past Month of Moderate Exercise
Variable
Coefficient
t
Intercept
2.01
5.75
PTSD
.
.
Non-PTSD
-.34
-.74
Time 1
.06
.18
Time 2
.20
.65
Time 3
-.14
-.53
Time 4
.
.
PTSD Diagnosis*Time 1
-.09
-.19
PTSD Diagnosis*Time 2
-.35
-.68
PTSD Diagnosis*Time 3
.26
.49
PTSD Diagnosis*Time 4
.
.
HRQOL Limited
-.02
-2.28
Activity
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df
38.80
.
38.80
38.80
38.80
38.80
.
38.80
38.80
38.80
.
38.80

p
< .01
.
.47
.86
.52
.60
.
.85
.50
.63
.
< .05

	
  

Figure 11. Trajectories of number of minutes of moderate activity over time.

Table 20 (Prospective Data : N = 30)
Number of Minutes of Moderate Exercise in the Past Month
Variable
Coefficient
t
Intercept
35.16
1.31
PTSD
.
.
Non-PTSD
-12.50
-.30
Time 1
-6.59
-.20
Time 2
-8.92
-.29
Time 3
48.32
1.74
Time 4
.
.
PTSD Diagnosis*Time 1
19.20
.40
PTSD Diagnosis*Time 2
14.77
.30
PTSD Diagnosis*Time 3
-59.60
-1.01
PTSD Diagnosis*Time 4
.
.

df
43.88
.
43.88
43.88
43.88
43.88
.
43.88
43.88
43.88
.

p
.20
.
.77
.84
.77
.09
.
.70
.77
.32
.

We also evaluated the impact of PTSD symptoms on longitudinal changes in
participants’ engagement in strenuous activity (causing sweating/breathing hard). To
assess differences between the positive and negative PTSD screen groups in the number
of days participants engaged in strenuous activity during a typical week (past month), we
conducted hierarchical linear models to analyze a data structure where participant number
of days of strenuous activity (level-1) was nested within participants and PTSD screen
(level-2). There was no main effect for PTSD and the PTSD x Time interaction was not
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significant. Time showed and overall effect (F(3, 55.86) = 3.69, p < .05) such that at 12
weeks (M = 1.18, SE = 1.22) participants reported significantly fewer days of strenuous
activities compared to 4 weeks (M = 2.11, SE = 1.17) and 8 weeks (M = 2.47, SE = 1.30),
returning to a level that was similar to baseline.

Figure 12. Trajectories of number of strenuous activity over time.

Table 21 (Prospective Data: N = 31)
Days of Strenuous Activity in the Past Month
Variable
Coefficient
Intercept
.11
PTSD
.
Non-PTSD
-.08
Time 1
.09
Time 2
.25
Time 3
.26
Time 4
.
PTSD Diagnosis*Time 1
.06
PTSD Diagnosis*Time 2
-.002
PTSD Diagnosis*Time 3
.12
PTSD Diagnosis*Time 4
.

	
  

t
1.06
.
-.49
.67
2.04
2.30
.
.28
-.01
.47
.

73	
  

df
55.86
.
55.86
55.86
55.86
55.86
.
55.86
55.86
55.86
.

p
.29
.
.63
.51
< .05
< .05
.
.78
.99
.64
.

	
  
Exercise Motivation. In conjunction with exercise behavior, we evaluated the
longitudinal relationships between PTSD symptoms and motivation to engage in
exercise. To test hypothesis 2c, assessing differences in motivations to begin preparing to
change exercise behaviors between the positive and negative PTSD screen groups, we
conducted hierarchical linear models to analyze a data structure where participant
preparatory motivation (level-1) was nested within participants and PTSD diagnosis
(level-2). There was no main effect for PTSD diagnosis or Time and the PTSD x Time
interaction was not significant.

Figure 13. Trajectories of exercise motivation (Preparation) over time.

Table 22 (N = 30)
Prospective Data Estimates Motivation to Exercise (Preparation) for Participants
Variable
Coefficient
t
df
Intercept
10.00
6.94
57.94
PTSD
.
.
.
Non-PTSD
-.06
-.03
57.80
Time 1
.95
.57
39.25
Time 2
-.25
-.15
36.12
Time 3
-.49
-.27
34.81
Time 4
.
.
.
PTSD Diagnosis*Time 1
-1.01
-.41
42.24
PTSD Diagnosis*Time 2
1.00
.34
41.84
PTSD Diagnosis*Time 3
3.46
.98
44.81
PTSD Diagnosis*Time 4
.
.
.
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p
< .01
.
.98
.57
.88
.79
.
.69
.74
.33
.

	
  
Next, we evaluated the impact of PTSD symptoms on longitudinal changes in
motivation to actively engage in exercise. To assess differences between the positive and
negative PTSD screen groups in action oriented motivation related to engaging in
exercise behaviors, we conducted hierarchical linear models to analyze a data structure
where action oriented motivation (level-1) was nested within participants and PTSD
diagnosis (level-2). After controlling for limitation due to pain, PTSD diagnosis had a
main effect (F(1, 35.62) = 7.34, p < .05) such that the PTSD group (M = 11.52, SE = .94)
had a greater mean than the non-PTSD group (M = 5.86, SE = 1.74). The main effect of
Time was not significant, neither was the PTSD x Time interaction. The HRQOL control
variable number of days of limitation due to pain (past month) was predictive of lower
action oriented motivation to engage in exercise.
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Figure 14. Trajectories of exercise motivation (Action) over time.

Table 23 (N = 28)
Prospective Data Estimates Motivation to Exercise (Action) for MOVE! Program Participants
Variable
Coefficient
t
df
p
Intercept
12.13
5.86
41.87
< .01
PTSD
.
.
.
.
Non-PTSD
-3.50
-.76
41.87
.45
Time 1
3.06
1.41
41.87
.17
Time 2
3.90
1.80
41.87
.08
Time 3
3.14
1.60
41.87
.12
Time 4
.
.
.
.
PTSD Diagnosis*Time 1
-2.37
-.49
41.87
.63
PTSD Diagnosis*Time 2
-4.49
-.85
41.87
.40
PTSD Diagnosis*Time 3
-1.78
-.36
41.87
.72
PTSD Diagnosis*Time 4
.
.
.
.
HRQOL Pain
-.20
-2.96
41.87
< .01

Finally, we evaluated the impact of PTSD symptoms on longitudinal changes in
motivation to sustain exercise behavior. To assess differences between the positive and
negative PTSD screen groups on motivation to maintain exercise behaviors, we
conducted hierarchical linear models to analyze a data structure where motivation to
maintain exercise habits (level-1) was nested within participants and PTSD diagnosis
(level-2). After controlling for number of days of limitation, there was a main effect for
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PTSD (F(1, 33.60) = 6.54, p < .05) such that the positive PTSD screen group (M = 11.33,
SE = .92) had a higher mean than those with a negative screen (M = 7.14, SE = 1.22).
There was no main effect for Time and the PTSD x Time interaction was not significant.
The HRQOL control variable number of days of limitation due to physical/mental health
(past month) was predictive of lower motivation to maintain exercise behavior.

Figure 15. Trajectories of exercise motivation (Maintenance) over time.

Table 24 (N = 28)
Prospective Data Estimates Motivation to Exercise (Maintenance) for Participants
Variable
Coefficient
t
df
Intercept
13.76
6.63
41.84
PTSD
.
.
.
Non-PTSD
-2.63
-.95
41.84
Time 1
.90
.48
41.84
Time 2
1.35
.71
41.84
Time 3
.55
.33
41.84
Time 4
.
.
.
PTSD Diagnosis*Time 1
-2.13
-.74
41.84
PTSD Diagnosis*Time 2
-3.16
-.96
41.84
PTSD Diagnosis*Time 3
-.93
-.27
41.84
PTSD Diagnosis*Time 4
.
.
.
HRQOL Limited
-.25
-3.86
41.84
Activity
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p
< .01
.
.35
.64
.48
.74
.
.46
.34
.79
.
< .01

	
  

Exercise Barriers. To evaluate the role of potential hindrances to engaging in
exercise behaviors, we evaluated the longitudinal relationship of the impact of PTSD
symptoms on perceived barriers to participating in exercise. To assess hypothesis 2d,
assessing differences in perceived barriers to exercise between the positive and negative
PTSD screen groups we conducted hierarchical linear models to analyze a data structure
where perceived barriers to exercise (level-1) was nested within participants and PTSD
(level-2). After controlling for AUDIT scores, there was no main effect for PTSD
diagnosis or Time and the PTSD x Time interaction was not significant. AUDIT scores
were predictive of lower perceived barriers to exercise.
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Figure 16. Trajectories of perceived barriers to exercise over time.

Table 25 (N = 23)
Prospective Data Estimates for Perceived Barriers to Exercise of MOVE! Program Participants
Variable
Coefficient
t
df
p
Intercept
30.51
13.71
25.17
< .01
PTSD
.
.
.
.
Non-PTSD
-5.34
-.96
25.17
.35
Time 1
-.36
-.15
25.17
.88
Time 2
-1.01
-.49
25.17
.63
Time 3
-.25
-.14
25.17
.89
Time 4
.
.
.
.
PTSD Diagnosis*Time 1
4.13
.73
25.17
.47
PTSD Diagnosis*Time 2
2.64
.49
25.17
.63
PTSD Diagnosis*Time 3
11.62
1.60
25.17
.12
PTSD Diagnosis*Time 4
.
.
.
.
AUDIT
-.98
-2.86
25.17
< .01

Self-regulation. We then looked at the impact of PTSD on changes in
participants’ abilities to modulate their behavior in the service of achieving futureoriented outcomes, To evaluate hypothesis 2e, assessing differences between the positive
and negative PTSD screen groups in self-regulation, we conducted hierarchical linear
models to analyze a data structure where participant self-regulation skills (level-1) was
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nested within participants and PTSD diagnosis (level-2). There was no main effect for
PTSD diagnosis or Time and the PTSD x Time interaction was not significant.

Figure 17. Trajectories of subjective ability to self-regulate over time.

Table 26 (N = 29)
Prospective Data Estimates Self-Regulation for MOVE! Program Participants
Variable
Coefficient
t
df
Intercept
104.31
20.05
29.70
PTSD
.
.
.
Non-PTSD
-4.04
-.52
29.70
Time 1
-3.15
-.70
29.70
Time 2
-4.98
-1.20
29.70
Time 3
-1.07
.30
29.70
Time 4
.
.
.
PTSD Diagnosis*Time 1
10.81
1.53
29.70
PTSD Diagnosis*Time 2
19.07
2.53
29.70
PTSD Diagnosis*Time 3
3.32
.50
29.70
PTSD Diagnosis*Time 4
.
.
.

p
< .01
.
.61
.49
.24
.77
.
.14
< .05
.62
.

PTSD Symptoms. Lastly, we evaluated changes in PTSD symptoms for
participants from the beginning to the end of study 2. To test hypothesis 3, assessing
changes in PTSD symptoms of PTSD participants while in the MOVE! program, we
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conducted hierarchical linear models in a data structure where PTSD symptoms (level-1)
was nested within participants (level-2). Exercise was entered at level-1 predicting PTSD
symptoms. There was no main effect for time, suggesting the lack of significant changes
in PTSD symptoms over the course of the study. Exercise was not significantly predictive
of PTSD symptoms.

Figure 18. Trajectory of PTSD symptoms over time.

Summary
The results of our archival analyses (Study 1) did not yield any statistically
differences between the PTSD and non-PTSD groups. The results of the prospective
analyses, derived from Study 2, yielded statistically significant group differences on two
variables related to motivation for exercise, such that the PTSD group evidenced higher
motivation compared to the non-PTSD group. There was also a statistically significant
main effect of time for the number of days participants engaged in strenuous activities
such that participants engaged in less frequent strenuous activity at 12 weeks compared to
4 and 8 weeks, with no difference between the PTSD and non-PTSD groups.
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Discussion
The purpose of the present investigation was to evaluate the effectiveness of the
MOVE! weight management program for veterans with PTSD, to assess exercise-related
changes in PTSD symptoms and to assess differences in exercise motivation and attitudes
between veterans with and without PTSD. Prior research has focused on the overall
effectiveness of the MOVE! program in decreasing veteran body weight and found that
veterans experience statistically significant decreases in weight (Littman et al., 2012).
The present study was designed to provide a glimpse into understanding the impact of
PTSD symptoms on weight management efforts. Importantly, PTSD is also linked with a
number of physical health comorbidities, most notably obesity and cardiovascular
disease. Veterans are a population at increased risk for developing PTSD and its
correlates and the MOVE! weight management program was developed to address the
high levels of overweight and obesity in this population. To date, no other studies have
looked at the differential effectiveness of the MOVE! weight management program for
patients diagnosed with PTSD with respect to their non-PTSD counterparts.
Summary
The results of the analyses conducted with archival data in Study 1 suggest that
the MOVE! program was effective in helping participants reduce their body weight an
average of two pounds. These findings are consistent with prior research on the MOVE!
program (Littman et al., 2012; Taft et al., 2011). Contrary to what we expected, we did
not find a continued trend towards decreased weight after participation in the weight
management program. Despite this, it is important to note that participants maintained
this decreased weight at one year after their last MOVE! session. This is notable as
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weight regain is common in the first year after the completion of weight-loss programs
(Curioni and Lourenco, 2005). We examined the effect of PTSD status on a number of
physical health indicators that tend to show a relation to weight, and we found no
differences between groups. In the archival sample, partner status played an interesting
role as married participants tended to weigh more than other participants (never married,
divorced, widowed), yet had decreased diastolic blood pressure when compared to a
subset of participants (never married). These findings suggest that marriage may
simultaneously function as a risk factor for increased weight and as a protective factor for
blood pressure. These findings suggest that married individuals may need to be more
cognizant of their body weight. Additionally, it may be important for clinicians to
encourage veterans to develop strong and satisfying social support networks, especially
among those who are widowed or never married.
Contrary to our hypothesis, PTSD did not significantly impact patients’
completion of the MOVE! program, as dropout rates were not statistically different
between the PTSD and non-PTSD groups and if anything a trend suggested better
adherence for the PTSD group. Additionally, PTSD did not seem to adversely impact
outcomes in either Study 1 or Study 2. Physical pain, however, was inversely associated
with motivation for exercise. In light of studies suggesting that exercise may be an
effective intervention for PTSD symptoms, we investigated whether this was true in
Study 2, but found that PTSD symptoms were not affected by exercise.
Findings from Archival Data (Study 1)
Vital Signs. The results from our archival data suggest that PTSD diagnosis was
not predictive of vital signs or laboratory tests. These results do not support our
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hypothesis that PTSD diagnosis would negatively impact the trajectory of participant’s
health indicators during their participation in the MOVE! weight management program. It
is possible that the effect of PTSD in the sample was attenuated by the general severity of
the sample’s health, as participants had, on average, nearly 20 comorbid psychological
and medical conditions. The results of our archival data point to age-typical trajectories
for vital signs and laboratory testing in our sample (Christou & Seals, 2008; Izzo, 2001;
Pickering et al., 2005).
When evaluating the trajectory of vital signs over time, there was no main effect
of time for any of the vital signs, nor was there a significant PTSD group effect. Age was
predictive of decreases in diastolic blood pressure and increases in systolic blood pressure
and respiratory rates. The connections between age and diastolic blood pressure are
consistent with research that documents age-related decreases in these vital signs
(Christou & Seals, 2008; Pickering et al., 2005). As noted above, partner status was
predictive of diastolic blood pressure such that married participants had lower diastolic
blood pressures than participants who were widowed and had never married. These
results are consistent with research that indicates that individuals who are more socially
isolated or endorse lower levels of social support are more likely to develop
cardiovascular disease than those with more satisfying social networks (Nealey-Moore,
Smith, Uchino, Hawkins, & Olson-Cerny, 2007). The relationship between systolic blood
pressure and age is consistent with research stating that as individuals age a number of
processes (hardening of the arteries, increased sensitivity to salts, decreased kidney
functioning, etc.) result in increased blood pressure through the lifespan (Izzo, 2001).
Age is not typically predictive of changes in respiratory rate, though older age is
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associated with declines in lung functioning and some research suggests that increased
respiratory rate is not uncommon in the elderly and may be an important indicatory of
respiratory tract infection (Sharma & Goodwin, 2006; McFadden, Price, Eastwood, &
Briggs, 1982).
Laboratory Testing. When evaluating the trajectory of cholesterol and blood
glucose over time, there was no treatment effect on either of these outcomes.
Additionally, the PTSD and non-PTSD groups did not differ in their cholesterol or blood
glucose levels. Age was a significant predictor of higher blood glucose. This finding is
consistent with research that points to increases in insulin resistance and the failure of the
pancreas to create sufficient amounts of insulin to overcome this resistance (Grant &
Meigs, 2004). Age also had a negative association with cholesterol levels. These findings
are consistent with prospective medical research suggesting that cholesterol levels have a
curvilinear trend over time, with cholesterol levels generally increasing over the lifespan
before declining around the age of 70 (Ferrara, Barrett-Connor, & Shan, 1997; Schaefer,
Lichtenstein, Lamon-Fava, McNamara, & Ordovas, 1995). A participant’s number of
comorbid diagnoses was also positively associated with increased blood glucose.
Increased blood glucose is associated with medical conditions frequently present in
overweight and obese individuals namely diabetes, insulin resistance, and glucose
intolerance (Kahn & Flier, 2000).
Findings from Prospectively Collected Data (study 2)
In the prospective study, we did not find differential dropout between the PTSD
and non-PTSD groups. Our small sample size limited power for detecting group
differences in dropout for this analysis. In this sample, there was no main effect of time
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on weight and the only significant time effect was a decrease in the number of days a
participant engaged in strenuous activity at 12 weeks. The findings from our prospective
sample are consistent with findings from the weight-management program literature, that
indicate a wide range of weight outcomes with studies resulting in little to no decreases in
mean weights to notable decreases in weight (Jain et al., 2004).
The results from the prospective data suggest that PTSD is not predictive of
exercise behavior and that one’s perception of their physical and mental health may be an
important factor with respect to engaging in exercise. PTSD and non-PTSD participants
engaged in similar levels of exercise despite the PTSD group showing higher levels of
motivation to engage in and maintain exercise behavior. This may suggest that those with
PTSD need higher levels of motivation to engage in comparable levels of exercise to their
counterparts. Importantly, two aspects of functional health (individuals’ report of their
functional impairment due to mental or physical health, and pain) were predictive of
exercise behavior and motivation for exercise. This highlights the potential for pain and
other medical problems to derail weight-loss efforts for veterans enrolled in the MOVE!
program as pain decreases the likelihood of engaging in physical activity. Finally, the
MOVE! program’s exercise regimen may not be sufficiently structured or intense enough
to produce anxiolytic effects in veterans with PTSD. Increasing the structure of exercise
in the MOVE! program may be conducive to improving weight outcomes and inducing
anxiolytic effects. Additionally, this sample’s high levels of physical and psychological
comorbidiites complicate the picture for exercise-induced changes in PTSD symptoms.
Exercise Behavior and Attitudes. When evaluating the trajectory of exercise
behaviors and attitudes there was a main effect of time for strenuous activity, and PTSD
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symptoms were not predictive of physical activity levels. These findings suggest that
PTSD symptoms may not be a deterrent for engaging in exercise. Interestingly, the
number of days a participant engaged in strenuous activities was significantly less at 12
weeks compared to 4 and 8 weeks suggesting that clinician focus on motivation to sustain
exercise behavior may be of particular importance at the end of treatment. The decline in
the number of days in which participants engaged in strenuous activity at the end of the
12-week program may suggest decreases in motivation towards the end of the program
and may point to the need for a greater focus on motivational aspects of weight loss later
in treatment. Number of days of limitation due to mental/physical health was predictive
of fewer days participating in moderate exercise in a typical week. Thus, health-related
quality of life and a person’s perception of their limitations due to both mental and
physical health problems may be important in understanding a person’s exercise
behavior.
With respect to motivation to change exercise behaviors, PTSD symptoms were
predictive of action and maintenance-oriented motivation to change exercise such that
participants screening positive for PTSD had higher levels of both types of motivation
than those screening negative. Also, the number of days that a participant’s usual
activities were limited due to pain was predictive of decreases in action-oriented
motivation. In addition to this, the number of days a participant’s usual activities were
limited by their mental or physical health was predictive of decreased motivation to
maintain exercise behavior. These findings suggest that motivation to engage in exercise
may not be impaired in individuals screening positive for PTSD and may actually be
enhanced. Despite higher levels of motivation from the group screening positive for
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PTSD, there were not higher levels of physical activity. These findings suggest that
individuals screening positive for PTSD may need enhanced motivation for engaging in
amounts of exercise comparable to their non-PTSD comparisons. It is also important to
note that physical pain inhibited action-oriented motivation to change exercise, as chronic
pain is a common diagnosis among overweight and obese individuals. This may point to
the importance of increasing the focus on how to cope with pain and how to pace
activities for MOVE! participants. Additionally, the number of days a participant
reported that their physical or mental health limited their usual activities’ relationship to
maintaining exercise behavior suggests that one’s perception of their health is important
to the maintenance of exercise behavior.
In our prospective sample, PTSD symptoms were not predictive of perceived
barriers to exercise. We did find that AUDIT total score was predictive of decreases in
the perceived barriers to engaging in exercise. This finding is peculiar, but is consistent
with research that suggests that alcohol consumption and physical activity are positively
correlated (French, Popovici, & Maclean, 2009). This research suggests that individuals
who consume alcohol recognize the number of calories alcohol contains and may try to
overcompensate for the consumption of excessive calories by exercising. This motivation
is likely to be associated with a lowered perception of the barriers to engaging in physical
activity as found in the present study. Additionally, it is important for clinicians to be
aware of veterans’ struggles with mental and physical health as these have the potential to
decrease both exercise behavior and motivation to engage in exercise. Pain’s significant
relationship to decreased motivation to exercise highlights the importance for clinicians
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to address pain’s effect on behavior and motivation early and often in treatment with
overweight and obese veterans.
PTSD Symptoms. Finally, participants did not show decreases in PTSD
symptoms by the end of the program as measured by the PCL-M. These findings suggest
that the level of exercise associated with participation in the MOVE! program may not be
sufficient for inducing anxiolytic effects in veterans with PTSD.
Overall, these findings suggest that the MOVE! weight management program can
be just as effective for veterans with PTSD as those without, thus there is no reason not to
recommend MOVE! highly to veterans for whom this program is appropriate.
Additionally, motivation to engage in exercise behaviors may be particularly important
for veterans diagnosed with PTSD as higher levels of motivation were associated with
comparable levels of physical activity. In conjunction with this, all veterans in the
program exhibited decreased levels of strenuous activity at 12 weeks compared to 4 and
8-week follow-ups further pointing to the importance of motivation later in treatment.
This effort reflects the use of two different samples in order to address a set of
related questions about the effect of the MOVE! program on veterans with PTSD. There
were a number of strengths, including the use of longitudinal data from both a large,
representative sample with objectively observed outcome variables, and from a smaller
sample who completed self-report measures of constructs relevant to the aims of the
MOVE! program. There were several limitations to study 2, reflecting constraints of
collecting data in a clinical environment. There was a high degree of treatment dropout
and the small sample size of the prospective study is a significant limitation.
Additionally, the use of the PCL for determining PTSD symptoms is not ideal, as a
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structured interview would have given us more definitive information in order to assign
PTSD diagnoses.
A future study that was adequately powered to test differences in the trajectories
over time might yield richer information about the effect of PTSD on exercise behavior.
Additionally, a large-scale study that included both laboratory measures as well as selfreport questionnaires could address many of these research questions simultaneously. To
elucidate the relationship between physical activity and PTSD symptoms, future research
should use manualized treatments for determining the dose of exercise necessary to
achieve anxiolytic effects in veterans with PTSD.
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